HIPK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00257 | T497 | GPS6|EPSD|PSP | CBX4 | CVKTRSEAGEPPSSLQVKPEtPASAAVAVAAAAAPTTTAEK |
| O15297 | S54 | SIGNOR|PSP | PPM1D WIP1 | tAEEKPsPRRSLSQPLPPRPsPAALPGGEVSGKGPAVAARE |
| O15297 | S85 | SIGNOR|EPSD|PSP | PPM1D WIP1 | GKGPAVAAREARDPLPDAGAsPAPSRCCRRRSSVAFFAVCD |
| O15379 | S374 | SIGNOR|PSP | HDAC3 | YLDQIRQTIFENLKMLNHAPsVQIHDVPADLLTYDRTDEAD |
| O43255 | S28 | EPSD|PSP | SIAH2 | GPsANKPCsKQPPPQPQHtPsPAAPPAAATISAAGPGSSAV |
| O43255 | S68 | PSP | SIAH2 | VPAAAAVISGPGGGGGAGPVsPQHHELTSLFECPVCFDYVL |
| O43255 | T119 | PSP | SIAH2 | LVCNQCRQKLSCCPTCRGALtPSIRNLAMEKVASAVLFPCK |
| O43255 | T26 | PSP | SIAH2 | stGPsANKPCsKQPPPQPQHtPsPAAPPAAATISAAGPGSS |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75128 | T1228 | Sugiyama | COBL KIAA0633 | PPPPPPSQALSAPRTAsRFstGtLSNTADARQALMDAIRSG |
| O94842 | S178 | Sugiyama | TOX4 C14orf92 KIAA0737 | GGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLPSQ |
| O94842 | T176 | Sugiyama | TOX4 C14orf92 KIAA0737 | SLGGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLP |
| P04637 | S46 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | S263 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsF |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T737 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EKTKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRV |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P16220 | S257 | SIGNOR|PSP | CREB1 | TYQIRTAPTSTIAPGVVMAssPALPTQPAEEAARKREVRLM |
| P17096 | S36 | GPS6|SIGNOR|EPSD|PSP | HMGA1 HMGIY | QEKDGTEKRGRGRPRKQPPVsPGtALVGsQKEPsEVPtPKR |
| P17096 | T53 | GPS6|SIGNOR|EPSD|PSP | HMGA1 HMGIY | PPVsPGtALVGsQKEPsEVPtPKRPRGRPKGsKNKGAAKTR |
| P17096 | T78 | GPS6|EPSD|PSP | HMGA1 HMGIY | RGRPKGsKNKGAAKTRKTTTtPGRKPRGRPKKLEKEEEEGI |
| P17676 | S76 | PSP | CEBPB TCF5 PP9092 | PRPPAGELGsIGDHERAIDFsPyLEPLGAPQAPAPATATDT |
| P17676 | T235 | EPSD|PSP | CEBPB TCF5 PP9092 | AVPsGssGsLstsssssPPGtPsPADAKAPPTACyAGAAPA |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18846 | S198 | GPS6|EPSD | ATF1 | TYQIRttPsAtsLPQtVVMtsPVTLTSQTTKTDDPQLKREI |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P26367 | T281 | SIGNOR|EPSD | PAX6 AN2 | RRAKWRREEKLRNQRRQASNtPSHIPISSSFSTSVYQPIPQ |
| P26367 | T304 | SIGNOR|EPSD | PAX6 AN2 | HIPISSSFSTSVYQPIPQPTtPVSSFTSGSMLGRTDTALTN |
| P26367 | T373 | SIGNOR|EPSD | PAX6 AN2 | SYSCMLPTSPSVNGRSYDTYtPPHMQTHMNSQPMGTSGTTS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P29590 | S36 | EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | ARPQEPtMPPPEtPsEGRQPsPsPsPtERAPAsEEEFQFLR |
| P29590 | S38 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | PQEPtMPPPEtPsEGRQPsPsPsPtERAPAsEEEFQFLRCQ |
| P29590 | S8 | GPS6|SIGNOR|EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | _____________MEPAPARsPRPQQDPARPQEPtMPPPEt |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35222 | S33 | GPS6|EPSD | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPE |
| P35222 | S37 | GPS6 | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | DRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGKGNPEEEDV |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42166 | T74 | Sugiyama | TMPO LAP2 | PAGTNsKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42167 | T74 | Sugiyama | TMPO LAP2 | PAGTNSKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P46013 | S1131 | Sugiyama | MKI67 | tPGPsEEsMtDEKTTKIACKsPPPEsVDtPtstKQWPKRSL |
| P46013 | S2105 | Sugiyama | MKI67 | tPDHTEESttDDKTTKIACKsPPPEsMDtPTstRRRPKtPL |
| P46527 | S10 | SIGNOR|EPSD|PSP | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46531 | T2511 | EPSD|PSP | NOTCH1 TAN1 | SSPVDNTPSHQLQVPEHPFLtPsPEsPDQWssssPHSNVSD |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P49023 | S303 | Sugiyama | PXN | QRADGERCWAAGWPRDGGRssPGGQDEGGFMAQGKtGsssP |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P51608 | S216 | EPSD|PSP | MECP2 | TTRPKAATSEGVQVKRVLEKsPGKLLVKMPFQtsPGGKAEG |
| P51608 | S80 | SIGNOR|EPSD|PSP | MECP2 | GKAETsEGsGsAPAVPEAsAsPKQRRSIIRDRGPMYDDPTL |
| P52945 | S268 | GPS6|SIGNOR|EPSD | PDX1 IPF1 STF1 | VPPAAPVAAREGRLPPGLSAsPQPssVAPRRPQEPR_____ |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P56545 | S428 | EPSD|PSP | CTBP2 | PGGIPVTHNLPTVAHPSQAPsPNQPTKHGDNREHPNEQ___ |
| P57682 | S101 | EPSD|PSP | KLF3 BKLF | sLKFPSSHRRAsPGLSMPsssPPIKKysPPsPGVQPFGVPL |
| P57682 | S108 | EPSD|PSP | KLF3 BKLF | HRRAsPGLSMPsssPPIKKysPPsPGVQPFGVPLSMPPVMA |
| P57682 | S111 | EPSD|PSP | KLF3 BKLF | AsPGLSMPsssPPIKKysPPsPGVQPFGVPLSMPPVMAAAL |
| P57682 | S216 | EPSD|PSP | KLF3 BKLF | KIKIEPGIEPQRTDYYPEEMsPPLMNsVsPPQALLQENHPS |
| P57682 | S224 | EPSD|PSP | KLF3 BKLF | EPQRTDYYPEEMsPPLMNsVsPPQALLQENHPSVIVQPGKR |
| P57682 | S250 | EPSD|PSP | KLF3 BKLF | LQENHPSVIVQPGKRPLPVEsPDTQRKRRIHRCDYDGCNKV |
| P57682 | S71 | EPSD|PSP | KLF3 BKLF | EGLSHGIQMEPVDLTVNKRssPPsAGNsPssLKFPSSHRRA |
| P57682 | S78 | EPSD|PSP | KLF3 BKLF | QMEPVDLTVNKRssPPsAGNsPssLKFPSSHRRAsPGLSMP |
| P57682 | S92 | EPSD|PSP | KLF3 BKLF | PPsAGNsPssLKFPSSHRRAsPGLSMPsssPPIKKysPPsP |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q00059 | S160 | Sugiyama | TFAM TCF6 TCF6L2 | RKAMTKKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQE |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q01196 | S249 | GPS6|EPSD|PSP | RUNX1 AML1 CBFA2 | stAFNPQPQSQMQDTRQIQPsPPWsyDQsyQyLGSIAsPsV |
| Q01196 | S276 | GPS6|EPSD|PSP | RUNX1 AML1 CBFA2 | QsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSRLsT |
| Q01196 | T273 | GPS6|EPSD|PSP | RUNX1 AML1 CBFA2 | syDQsyQyLGSIAsPsVHPAtPIsPGRASGMTTLSAELSSR |
| Q04724 | S239 | PSP | TLE1 | EFSNDIKKRKVDDKDSSHYDsDGDKsDDNLVVDVsNEDPss |
| Q04724 | S286 | PSP | TLE1 | HsPRENGIDKNRLLKKDAsssPAstASSASSTSLKSKEMSL |
| Q04724 | S289 | PSP | TLE1 | RENGIDKNRLLKKDAsssPAstASSASSTSLKSKEMSLHEK |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q09472 | S2279 | PSP | EP300 P300 | AYQQRLLQQQMGSPVQPNPMsPQQHMLPNQAQSPHLQGQQI |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13363 | S422 | GPS6|SIGNOR|EPSD|PSP | CTBP1 CTBP | PSAMSLSHGLPPVAHPPHAPsPGQTVKPEADRDHASDQL__ |
| Q13428 | T1014 | Sugiyama | TCOF1 | ARssssEsEDEDVIPAtQCLtPGIRTNVVTMPTAHPRIAPK |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q13586 | S620 | Sugiyama | STIM1 GOK | sPsAPPGGsPHLDssRsHsPssPDPDtPsPVGDSRALQASR |
| Q14004 | S383 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | sRRRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVL |
| Q14160 | S1448 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | QEDEQPPWAsPsPtsRQsPAsPPPLGGGAPVRTAKAERRHQ |
| Q14160 | S1486 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RHQERLRVQsPEPPAPERALsPAELRALEAEKRALWRAARM |
| Q14247 | T401 | Sugiyama | CTTN EMS1 | RQEQEEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVy |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q5T0N5 | S501 | Sugiyama | FNBP1L C1orf39 TOCA1 | GRGDRRHssDINHLVtQGREsPEGsytDDANQEVRGPPQQH |
| Q6PD62 | S1125 | Sugiyama | CTR9 KIAA0155 SH2BP1 | ESVQSGRSHSGVsENDsRPAsPSAEsDHESERGSDNEGSGQ |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71RC2 | S597 | Sugiyama | LARP4 PP13296 | QttIPVsPPsttKPsRAstAsPCNNNINAAtAVALQEPRKL |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7L2J0 | S69 | Sugiyama | MEPCE BCDIN3 | RGPGRCAPsAGsPAAAVGREsPGAAAtsSSGPQAQQHRGGG |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z5L9 | S242 | Sugiyama | IRF2BP2 | ASLGSAQPTDLGAHKRPAsVsssAAVEHEQREAAAKEKQPP |
| Q86VQ1 | T350 | Sugiyama | GLCCI1 | RRAPLPAHYRssstRsIDTQtPsVQERSSSCSSHSPCVSPF |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q86Z02 | S342 | Sugiyama | HIPK1 KIAA0630 MYAK NBAK2 | MLVDPVRQPYRVKVIDFGSAsHVSKAVCstyLQsRYYRAPE |
| Q86Z02 | Y352 | Sugiyama | HIPK1 KIAA0630 MYAK NBAK2 | RVKVIDFGSAsHVSKAVCstyLQsRYYRAPEIILGLPFCEA |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8ND56 | S183 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GSAFTQDTRsLKtQLsQGRssPQLDPLRKsPtMEQAVQtAs |
| Q8TEW0 | T965 | Sugiyama | PARD3 PAR3 PAR3A | MEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQEKG |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | T120 | Sugiyama | GATAD2B KIAA1150 | INDEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSs |
| Q8WY36 | S844 | Sugiyama | BBX HBP2 | KRKARKTKITHLVRtADGRVsPAGGTLDDKPKEQLQRSLPK |
| Q96B36 | S212 | Sugiyama | AKT1S1 PRAS40 | GFKEKRtEARssDEENGPPssPDLDRIAAsMRALVLREAED |
| Q96EB6 | S27 | EPSD|PSP | SIRT1 SIR2L1 | LALQPGGsPsAAGADREAAssPAGEPLRKRPRRDGPGLERs |
| Q96EB6 | S682 | EPSD|PSP | SIRT1 SIR2L1 | EDDVLSSsSCGSNSDSGTCQsPSLEEPMEDESEIEEFYNGL |
| Q96G74 | S64 | Sugiyama | OTUD5 | GVGGGDRDRDsGVVGARPRAsPPPQGPLPGPPGALHRWALA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q99607 | S369 | PSP | ELF4 ELFR MEF | EKPKIQHVGLQPSASLELGPsLDEEIPTTSTMLVSPAEGQV |
| Q9BQ16 | T118 | Sugiyama | SPOCK3 TICN3 UNQ409/PRO771 | HKVCIAQDSQTAVCISHRRLtHRMKEAGVDHRQWRGPILST |
| Q9BY44 | S506 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | KNQRKHEAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQs |
| Q9BY44 | T512 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | EAKKAAKQEARsDKsPDLAPtPAPQstPRNtVsQsIsGDPE |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H2X6 | S1013 | Sugiyama | HIPK2 | HHSSSYKSKSSSNVTSTSGHssGSSSGAITYRQQRPGPHFQ |
| Q9H2X6 | S1014 | Sugiyama | HIPK2 | HSSSYKSKSSSNVTSTSGHssGSSSGAITYRQQRPGPHFQQ |
| Q9H2X6 | S118 | Sugiyama | HIPK2 | ASSTSVTGQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEI |
| Q9H2X6 | S121 | Sugiyama | HIPK2 | TSVTGQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIENT |
| Q9H2X6 | S351 | Sugiyama | HIPK2 | MLVDPSRQPYRVKVIDFGSAsHVSKAVCstyLQsRYyRAPE |
| Q9H2X6 | S364 | EPSD|PSP | HIPK2 | VIDFGSAsHVSKAVCstyLQsRYyRAPEIILGLPFCEAIDM |
| Q9H2X6 | S37 | Sugiyama | HIPK2 | PHTLQSSAFCSVKKLKIEPSsNWDMtGyGsHsKVYSQSKNI |
| Q9H2X6 | S441 | Sugiyama | HIPK2 | AEYLLSAGTKTTRFFNRDTDsPYPLWRLKTPDDHEAETGIK |
| Q9H2X6 | S46 | Sugiyama | HIPK2 | CSVKKLKIEPSsNWDMtGyGsHsKVYSQSKNIPLSQPATTT |
| Q9H2X6 | S48 | Sugiyama | HIPK2 | VKKLKIEPSsNWDMtGyGsHsKVYSQSKNIPLSQPATTTVS |
| Q9H2X6 | S668 | PSP | HIPK2 | PDPFQQALIVCPPGFQGLQAsPSKHAGYSVRMENAVPIVTQ |
| Q9H2X6 | S815 | Sugiyama | HIPK2 | PTSTTSSRKSKQHQSSVRNVstCEVSSSQAIssPQRSKRVK |
| Q9H2X6 | S827 | PSP|Sugiyama | HIPK2 | HQSSVRNVstCEVSSSQAIssPQRSKRVKENtPPRCAMVHs |
| Q9H2X6 | S848 | PSP | HIPK2 | PQRSKRVKENtPPRCAMVHssPACstsVTCGWGDVASSTTR |
| Q9H2X6 | S882 | SIGNOR|EPSD|PSP | HIPK2 | VASSTTRERQRQTIVIPDtPsPTVSVITISSDTDEEEEQKH |
| Q9H2X6 | S924 | PSP | HIPK2 | PTSTVSKQRKNVISCVTVHDsPYSDSSSNtsPYSVQQRAGH |
| Q9H2X6 | S934 | PSP | HIPK2 | NVISCVTVHDsPYSDSSSNtsPYSVQQRAGHNNANAFDtKG |
| Q9H2X6 | S955 | Sugiyama | HIPK2 | PYSVQQRAGHNNANAFDtKGsLENHCtGNPRTIIVPPLKTQ |
| Q9H2X6 | S985 | Sugiyama | HIPK2 | RTIIVPPLKTQASEVLVECDsLVPVNtSHHSSSYKSKSSSN |
| Q9H2X6 | T119 | Sugiyama | HIPK2 | SSTSVTGQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIE |
| Q9H2X6 | T125 | Sugiyama | HIPK2 | GQVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIENTSSVQ |
| Q9H2X6 | T42 | Sugiyama | HIPK2 | SSAFCSVKKLKIEPSsNWDMtGyGsHsKVYSQSKNIPLSQP |
| Q9H2X6 | T816 | Sugiyama | HIPK2 | TSTTSSRKSKQHQSSVRNVstCEVSSSQAIssPQRSKRVKE |
| Q9H2X6 | T838 | PSP | HIPK2 | EVSSSQAIssPQRSKRVKENtPPRCAMVHssPACstsVTCG |
| Q9H2X6 | T880 | SIGNOR|EPSD|PSP | HIPK2 | GDVASSTTRERQRQTIVIPDtPsPTVSVITISSDTDEEEEQ |
| Q9H2X6 | T952 | Sugiyama | HIPK2 | NtsPYSVQQRAGHNNANAFDtKGsLENHCtGNPRTIIVPPL |
| Q9H2X6 | T961 | Sugiyama | HIPK2 | RAGHNNANAFDtKGsLENHCtGNPRTIIVPPLKTQASEVLV |
| Q9H2X6 | T991 | Sugiyama | HIPK2 | PLKTQASEVLVECDsLVPVNtSHHSSSYKSKSSSNVTSTSG |
| Q9H2X6 | Y126 | Sugiyama | HIPK2 | QVLGGPHNLMRRstVsLLDtyQKCGLKRKSEEIENTSSVQI |
| Q9H2X6 | Y361 | EPSD|PSP|Sugiyama | HIPK2 | RVKVIDFGSAsHVSKAVCstyLQsRYyRAPEIILGLPFCEA |
| Q9H2X6 | Y44 | Sugiyama | HIPK2 | AFCSVKKLKIEPSsNWDMtGyGsHsKVYSQSKNIPLSQPAT |
| Q9H3D4 | T491 | EPSD|PSP | TP63 KET P63 P73H P73L TP73L | SMNKLPsVsQLINPQQRNALtPTTIPDGMGANIPMMGTHMP |
| Q9H422 | S349 | Sugiyama | HIPK3 DYRK6 FIST3 PKY | MLVDPVRQPYRVKVIDFGSAsHVSKTVCstyLQsRYYRAPE |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9NPI6 | S523 | Sugiyama | DCP1A SMIF | APSVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILS |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9P1Z0 | T795 | GPS6|SIGNOR|EPSD|PSP | ZBTB4 KIAA1538 | KTAAALSRHGQRHAAERPGGtPtPVIAYSKGSAGTRPGDVK |
| Q9P1Z0 | T797 | GPS6|SIGNOR|EPSD|PSP | ZBTB4 KIAA1538 | AAALSRHGQRHAAERPGGtPtPVIAYSKGSAGTRPGDVKEE |
| Q9P1Z0 | T983 | GPS6|SIGNOR|EPSD|PSP | ZBTB4 KIAA1538 | FLPGVFGYAVNPQAAPPAPPtPPPPTLPPPIPPKGEGERAG |
| Q9UBP0 | S268 | PSP | SPAST ADPSP FSP2 KIAA1083 SPG4 | RSKTVMKTGSAGLSGHHRAPsYsGLSMVSGVKQGSGPAPTT |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 9.344916e-09 | 8.029 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.353483e-08 | 7.134 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.589552e-07 | 6.018 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.512955e-05 | 4.820 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.612943e-05 | 4.017 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.474400e-04 | 3.831 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.905192e-04 | 3.408 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.411779e-04 | 3.355 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.983970e-04 | 3.223 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.595193e-04 | 3.252 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.900505e-04 | 3.161 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.431816e-04 | 3.129 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.102114e-03 | 2.958 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.231522e-03 | 2.910 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.438810e-03 | 2.842 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.622048e-03 | 2.790 | 1 | 1 |
| Circadian clock | R-HSA-9909396 | 1.406619e-03 | 2.852 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.593415e-03 | 2.798 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.153128e-03 | 2.667 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.992654e-03 | 2.701 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.139333e-03 | 2.670 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.402975e-03 | 2.619 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.752723e-03 | 2.560 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.752723e-03 | 2.560 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.654367e-03 | 2.576 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.789953e-03 | 2.554 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.351600e-03 | 2.475 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.039740e-03 | 2.394 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.695728e-03 | 2.328 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.721748e-03 | 2.326 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.447479e-03 | 2.352 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.721748e-03 | 2.326 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.932794e-03 | 2.227 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.076683e-03 | 2.216 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.908104e-03 | 2.229 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.631380e-03 | 2.117 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 8.014063e-03 | 2.096 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.486119e-03 | 2.071 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.025861e-02 | 1.989 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.564919e-03 | 2.019 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.125719e-02 | 1.949 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.961525e-03 | 2.002 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.098034e-02 | 1.959 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.125719e-02 | 1.949 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.076593e-02 | 1.968 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.250797e-02 | 1.903 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.231902e-02 | 1.909 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.231902e-02 | 1.909 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.154838e-02 | 1.937 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.129937e-02 | 1.947 | 1 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.207880e-02 | 1.918 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.199394e-02 | 1.921 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.477213e-02 | 1.831 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.477213e-02 | 1.831 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.499844e-02 | 1.824 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.548364e-02 | 1.810 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.585883e-02 | 1.800 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.729113e-02 | 1.762 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.730959e-02 | 1.762 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.840348e-02 | 1.735 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.847783e-02 | 1.733 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.799307e-02 | 1.745 | 1 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.848975e-02 | 1.733 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.577484e-02 | 1.589 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.577484e-02 | 1.589 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.577484e-02 | 1.589 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.577484e-02 | 1.589 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.017378e-02 | 1.695 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.349936e-02 | 1.629 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.349936e-02 | 1.629 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.635399e-02 | 1.579 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.342688e-02 | 1.630 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.409772e-02 | 1.618 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.466394e-02 | 1.608 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.303752e-02 | 1.638 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.599879e-02 | 1.585 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.454236e-02 | 1.610 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.017378e-02 | 1.695 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.302297e-02 | 1.638 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.492567e-02 | 1.603 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.184418e-02 | 1.661 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.302297e-02 | 1.638 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.657031e-02 | 1.576 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.949852e-02 | 1.530 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.949852e-02 | 1.530 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.468954e-02 | 1.460 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.468954e-02 | 1.460 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.468954e-02 | 1.460 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.468954e-02 | 1.460 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.362266e-02 | 1.473 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.362266e-02 | 1.473 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.128906e-02 | 1.505 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.496539e-02 | 1.456 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.205679e-02 | 1.494 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.053962e-02 | 1.515 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.948260e-02 | 1.530 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.335170e-02 | 1.477 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.362266e-02 | 1.473 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.128906e-02 | 1.505 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.053962e-02 | 1.515 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.083892e-02 | 1.511 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.421613e-02 | 1.466 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.199340e-02 | 1.495 | 1 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.402371e-02 | 1.468 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.501998e-02 | 1.456 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.501998e-02 | 1.456 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.520902e-02 | 1.453 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.772380e-02 | 1.423 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.722061e-02 | 1.429 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.714077e-02 | 1.430 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.645906e-02 | 1.438 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.839062e-02 | 1.416 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.839062e-02 | 1.416 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.578887e-02 | 1.446 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.772380e-02 | 1.423 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.839751e-02 | 1.416 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.848770e-02 | 1.415 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.014377e-02 | 1.396 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 4.389046e-02 | 1.358 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 4.389046e-02 | 1.358 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.326962e-02 | 1.364 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.326962e-02 | 1.364 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.518074e-02 | 1.345 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.312916e-02 | 1.365 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.173541e-02 | 1.379 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.312916e-02 | 1.365 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.569186e-02 | 1.340 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.607606e-02 | 1.337 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.954611e-02 | 1.305 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.962908e-02 | 1.304 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.093183e-02 | 1.293 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.208878e-02 | 1.283 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.434969e-02 | 1.265 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.476315e-02 | 1.262 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.392378e-02 | 1.268 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.034031e-02 | 1.298 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.453017e-02 | 1.263 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.034031e-02 | 1.298 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.376423e-02 | 1.270 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.500122e-02 | 1.260 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.500122e-02 | 1.260 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.724980e-02 | 1.242 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.268543e-02 | 1.139 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.268543e-02 | 1.139 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.268543e-02 | 1.139 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.268543e-02 | 1.139 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.969279e-02 | 1.224 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.969279e-02 | 1.224 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.969279e-02 | 1.224 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.969279e-02 | 1.224 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.969279e-02 | 1.224 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.259977e-02 | 1.139 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.259977e-02 | 1.139 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.490404e-02 | 1.188 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.593559e-02 | 1.181 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.969279e-02 | 1.224 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.122127e-02 | 1.213 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.035754e-02 | 1.153 | 1 | 1 |
| Signal Transduction | R-HSA-162582 | 5.998427e-02 | 1.222 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.286360e-02 | 1.137 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.518995e-02 | 1.186 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.122127e-02 | 1.213 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.262199e-02 | 1.203 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.211929e-02 | 1.142 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.490404e-02 | 1.188 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.314217e-02 | 1.136 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.635218e-02 | 1.117 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.655095e-02 | 1.116 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 7.858984e-02 | 1.105 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.865072e-02 | 1.104 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.074932e-02 | 1.093 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.415575e-02 | 1.075 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.042618e-01 | 0.982 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.042618e-01 | 0.982 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.042618e-01 | 0.982 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.042618e-01 | 0.982 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.042618e-01 | 0.982 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.976586e-01 | 0.704 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.976586e-01 | 0.704 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.976586e-01 | 0.704 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.976586e-01 | 0.704 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.058702e-01 | 0.975 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.058702e-01 | 0.975 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.422175e-01 | 0.847 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.422175e-01 | 0.847 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.422175e-01 | 0.847 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.422175e-01 | 0.847 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.813220e-01 | 0.551 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.813220e-01 | 0.551 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.813220e-01 | 0.551 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.813220e-01 | 0.551 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.813220e-01 | 0.551 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.813220e-01 | 0.551 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.813220e-01 | 0.551 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.813220e-01 | 0.551 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.973637e-02 | 1.001 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 9.973637e-02 | 1.001 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.973637e-02 | 1.001 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.973637e-02 | 1.001 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.807079e-01 | 0.743 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.807079e-01 | 0.743 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.807079e-01 | 0.743 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.807079e-01 | 0.743 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.807079e-01 | 0.743 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.807079e-01 | 0.743 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.228789e-01 | 0.911 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.598777e-02 | 1.066 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.025313e-01 | 0.989 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.025313e-01 | 0.989 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.477486e-01 | 0.830 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.477486e-01 | 0.830 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.205002e-01 | 0.657 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.205002e-01 | 0.657 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.205002e-01 | 0.657 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.205002e-01 | 0.657 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.562659e-01 | 0.448 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.562659e-01 | 0.448 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.562659e-01 | 0.448 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.562659e-01 | 0.448 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.562659e-01 | 0.448 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.562659e-01 | 0.448 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.562659e-01 | 0.448 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.505081e-02 | 1.070 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.505081e-02 | 1.070 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.609048e-01 | 0.584 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.609048e-01 | 0.584 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.609048e-01 | 0.584 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.232858e-02 | 1.035 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.015773e-01 | 0.696 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.597411e-01 | 0.797 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.448688e-01 | 0.839 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.809580e-01 | 0.742 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.809580e-01 | 0.742 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.300041e-01 | 0.638 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.300041e-01 | 0.638 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.300041e-01 | 0.638 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.013619e-01 | 0.521 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.013619e-01 | 0.521 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.013619e-01 | 0.521 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.233986e-01 | 0.373 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.233986e-01 | 0.373 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.233986e-01 | 0.373 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.233986e-01 | 0.373 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.233986e-01 | 0.373 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.233986e-01 | 0.373 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.233986e-01 | 0.373 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.233986e-01 | 0.373 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.750188e-02 | 1.058 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.066963e-01 | 0.972 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.620703e-01 | 0.790 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.591037e-01 | 0.587 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.591037e-01 | 0.587 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.800436e-01 | 0.745 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.304627e-01 | 0.885 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.414216e-01 | 0.467 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.414216e-01 | 0.467 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.886444e-01 | 0.540 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.886444e-01 | 0.540 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.886444e-01 | 0.540 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.492966e-01 | 0.603 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.180139e-01 | 0.662 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.468465e-01 | 0.833 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.468465e-01 | 0.833 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.468465e-01 | 0.833 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.468465e-01 | 0.833 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.090477e-01 | 0.680 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.378582e-01 | 0.624 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.732134e-01 | 0.563 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.732134e-01 | 0.563 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.184128e-01 | 0.497 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.807271e-01 | 0.419 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.807271e-01 | 0.419 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.835338e-01 | 0.316 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.835338e-01 | 0.316 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.835338e-01 | 0.316 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.835338e-01 | 0.316 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.835338e-01 | 0.316 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.774583e-01 | 0.751 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.938039e-02 | 1.003 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.361984e-01 | 0.866 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.152359e-01 | 0.667 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.440813e-01 | 0.612 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.482148e-01 | 0.458 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.788752e-01 | 0.555 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.190002e-01 | 0.378 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.998919e-01 | 0.523 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.998919e-01 | 0.523 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.998919e-01 | 0.523 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.778760e-01 | 0.423 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.636258e-01 | 0.579 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.470788e-01 | 0.832 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.466693e-01 | 0.460 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.211455e-01 | 0.493 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.211455e-01 | 0.493 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.211455e-01 | 0.493 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.211455e-01 | 0.493 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.893723e-01 | 0.723 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.974204e-01 | 0.527 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.974204e-01 | 0.527 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.974204e-01 | 0.527 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.974204e-01 | 0.527 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.425620e-01 | 0.465 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.425620e-01 | 0.465 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.713511e-01 | 0.430 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.072419e-01 | 0.390 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.072419e-01 | 0.390 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.560289e-01 | 0.341 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.560289e-01 | 0.341 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.560289e-01 | 0.341 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.560289e-01 | 0.341 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.560289e-01 | 0.341 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.560289e-01 | 0.341 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.374005e-01 | 0.270 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.374005e-01 | 0.270 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.374005e-01 | 0.270 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.374005e-01 | 0.270 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.374005e-01 | 0.270 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.374005e-01 | 0.270 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.320683e-01 | 0.479 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.427258e-01 | 0.465 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.204114e-01 | 0.376 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.916567e-01 | 0.308 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.916567e-01 | 0.308 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.916567e-01 | 0.308 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.687927e-01 | 0.571 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.672506e-01 | 0.435 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.590205e-01 | 0.445 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.446166e-01 | 0.352 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.147380e-01 | 0.382 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.815209e-01 | 0.550 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.923031e-01 | 0.308 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.257730e-01 | 0.279 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.257730e-01 | 0.279 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.257730e-01 | 0.279 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.257730e-01 | 0.279 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.257730e-01 | 0.279 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.257730e-01 | 0.279 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.257730e-01 | 0.279 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.257730e-01 | 0.279 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.257730e-01 | 0.279 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.856518e-01 | 0.232 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.856518e-01 | 0.232 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.856518e-01 | 0.232 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.856518e-01 | 0.232 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.856518e-01 | 0.232 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.856518e-01 | 0.232 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.856518e-01 | 0.232 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.856518e-01 | 0.232 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.856518e-01 | 0.232 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.917891e-01 | 0.407 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.193110e-01 | 0.285 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.193110e-01 | 0.285 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.193110e-01 | 0.285 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.193110e-01 | 0.285 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.193110e-01 | 0.285 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.193110e-01 | 0.285 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.376122e-01 | 0.270 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.376122e-01 | 0.270 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.277758e-01 | 0.278 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.277758e-01 | 0.278 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.596253e-01 | 0.252 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.596253e-01 | 0.252 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.288728e-01 | 0.201 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.288728e-01 | 0.201 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.184823e-01 | 0.209 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.184823e-01 | 0.209 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.184823e-01 | 0.209 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.188600e-01 | 0.208 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.188600e-01 | 0.208 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.188600e-01 | 0.208 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.262051e-01 | 0.203 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.307945e-01 | 0.200 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.414417e-01 | 0.193 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.675877e-01 | 0.175 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.675877e-01 | 0.175 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.675877e-01 | 0.175 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.675877e-01 | 0.175 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.675877e-01 | 0.175 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.675877e-01 | 0.175 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.675877e-01 | 0.175 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.675877e-01 | 0.175 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.604270e-01 | 0.180 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.630635e-01 | 0.178 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.721404e-01 | 0.173 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.370976e-01 | 0.472 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.218118e-01 | 0.654 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.060998e-01 | 0.514 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.015964e-01 | 0.521 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.262051e-01 | 0.203 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.744763e-01 | 0.324 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.744763e-01 | 0.324 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.744763e-01 | 0.324 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.059091e-01 | 0.686 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.624028e-01 | 0.581 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.030417e-01 | 0.692 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.130477e-01 | 0.947 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.636258e-01 | 0.579 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.147380e-01 | 0.382 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.636258e-01 | 0.579 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.636258e-01 | 0.579 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.713511e-01 | 0.430 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.269686e-01 | 0.896 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.708730e-01 | 0.243 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.793699e-01 | 0.746 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.886444e-01 | 0.540 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.706979e-01 | 0.768 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.974919e-01 | 0.527 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.190002e-01 | 0.378 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.208824e-01 | 0.656 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.354757e-01 | 0.197 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.591037e-01 | 0.587 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.220145e-01 | 0.492 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.381225e-01 | 0.860 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.534347e-01 | 0.596 | 1 | 1 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.147380e-01 | 0.382 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.205042e-01 | 0.207 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.013619e-01 | 0.521 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.258640e-01 | 0.646 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.920023e-01 | 0.308 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.892137e-01 | 0.230 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.015773e-01 | 0.696 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.190002e-01 | 0.378 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.916567e-01 | 0.308 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.284795e-01 | 0.368 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.620561e-01 | 0.179 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.257730e-01 | 0.279 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.596253e-01 | 0.252 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.072419e-01 | 0.390 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.923031e-01 | 0.308 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.708730e-01 | 0.243 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.304627e-01 | 0.885 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.100695e-01 | 0.678 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.740716e-01 | 0.759 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.190002e-01 | 0.378 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.998919e-01 | 0.523 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.273049e-01 | 0.895 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.954190e-01 | 0.403 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.082485e-01 | 0.389 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.856518e-01 | 0.232 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.517530e-01 | 0.258 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.770531e-01 | 0.239 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.596253e-01 | 0.252 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.048262e-01 | 0.218 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.591037e-01 | 0.587 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.468465e-01 | 0.833 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.622057e-01 | 0.581 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.604270e-01 | 0.180 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.482148e-01 | 0.458 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.701490e-01 | 0.769 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.119277e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.596253e-01 | 0.252 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.160589e-01 | 0.381 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.257530e-01 | 0.900 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.682181e-01 | 0.774 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.813220e-01 | 0.551 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.309382e-01 | 0.883 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.492966e-01 | 0.603 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.180139e-01 | 0.662 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.807271e-01 | 0.419 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.835338e-01 | 0.316 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 5.856518e-01 | 0.232 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.897310e-01 | 0.310 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.184823e-01 | 0.209 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.675877e-01 | 0.175 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.185258e-01 | 0.209 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.713511e-01 | 0.430 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.432554e-01 | 0.844 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.630635e-01 | 0.178 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.942531e-01 | 0.712 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.573839e-01 | 0.340 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.305241e-01 | 0.481 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.727974e-01 | 0.429 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.494386e-01 | 0.347 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.515148e-01 | 0.258 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.336565e-01 | 0.363 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.740716e-01 | 0.759 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.732134e-01 | 0.563 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.152359e-01 | 0.667 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.446166e-01 | 0.352 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.727974e-01 | 0.429 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.257730e-01 | 0.279 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.604270e-01 | 0.180 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.913395e-01 | 0.536 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.531218e-01 | 0.344 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.922425e-01 | 0.534 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.371847e-01 | 0.270 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.581714e-01 | 0.588 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.497077e-01 | 0.347 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.726057e-01 | 0.242 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.120630e-01 | 0.385 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.119277e-01 | 0.291 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.782237e-01 | 0.169 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.807080e-01 | 0.552 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.121002e-01 | 0.506 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.807079e-01 | 0.743 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.620703e-01 | 0.790 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.258640e-01 | 0.646 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.057538e-01 | 0.976 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.807271e-01 | 0.419 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.853525e-01 | 0.732 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.374005e-01 | 0.270 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.737133e-01 | 0.241 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.220570e-01 | 0.206 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.675877e-01 | 0.175 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.675877e-01 | 0.175 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.690827e-02 | 1.014 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.745954e-01 | 0.324 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.188871e-01 | 0.660 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.188871e-01 | 0.660 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.371622e-01 | 0.270 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.506476e-01 | 0.455 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.212978e-01 | 0.655 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.504307e-01 | 0.601 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.183619e-01 | 0.497 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.257730e-01 | 0.279 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.493110e-01 | 0.260 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.361984e-01 | 0.866 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.217467e-01 | 0.654 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.217467e-01 | 0.654 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.217467e-01 | 0.654 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.217467e-01 | 0.654 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.422075e-01 | 0.616 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.579830e-01 | 0.801 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.685026e-01 | 0.329 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.576195e-02 | 1.019 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.422175e-01 | 0.847 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.422175e-01 | 0.847 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.025313e-01 | 0.989 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 2.205002e-01 | 0.657 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.232858e-02 | 1.035 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.233986e-01 | 0.373 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.624028e-01 | 0.581 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.916567e-01 | 0.308 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.872880e-01 | 0.412 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.685026e-01 | 0.329 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.288728e-01 | 0.201 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.497077e-01 | 0.347 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.767663e-01 | 0.239 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.309382e-01 | 0.883 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.014385e-01 | 0.994 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.765114e-01 | 0.239 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.605482e-01 | 0.180 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.525987e-01 | 0.258 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.537284e-01 | 0.185 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.609048e-01 | 0.584 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 4.835338e-01 | 0.316 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.803963e-01 | 0.552 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.974204e-01 | 0.527 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.916567e-01 | 0.308 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.645639e-01 | 0.333 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.685026e-01 | 0.329 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.920023e-01 | 0.308 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.184823e-01 | 0.209 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.184823e-01 | 0.209 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.401149e-01 | 0.194 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.854629e-02 | 1.006 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.105895e-01 | 0.956 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.395175e-01 | 0.855 | 1 | 1 |
| DNA Repair | R-HSA-73894 | 3.311594e-01 | 0.480 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.605025e-01 | 0.180 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.394421e-01 | 0.856 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.204114e-01 | 0.376 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.406594e-01 | 0.356 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.899274e-01 | 0.229 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.680776e-01 | 0.572 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.448844e-01 | 0.611 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.789406e-01 | 0.554 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.856017e-01 | 0.414 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.446166e-01 | 0.352 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.824840e-01 | 0.417 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.593222e-02 | 1.018 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.778760e-01 | 0.423 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.635742e-01 | 0.178 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.599109e-01 | 0.796 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.436536e-01 | 0.191 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.994439e-01 | 0.700 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.511948e-01 | 0.346 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.790005e-01 | 0.554 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.976586e-01 | 0.704 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.807079e-01 | 0.743 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.562659e-01 | 0.448 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 3.562659e-01 | 0.448 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.395175e-01 | 0.855 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.130477e-01 | 0.947 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.233986e-01 | 0.373 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.233986e-01 | 0.373 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.030417e-01 | 0.692 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.800436e-01 | 0.745 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.886444e-01 | 0.540 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.886444e-01 | 0.540 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.566224e-01 | 0.805 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.359022e-01 | 0.867 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.807271e-01 | 0.419 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.835338e-01 | 0.316 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.835338e-01 | 0.316 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.093100e-01 | 0.679 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.093100e-01 | 0.679 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.466693e-01 | 0.460 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.344651e-01 | 0.630 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.374005e-01 | 0.270 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.035075e-01 | 0.691 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.361769e-01 | 0.360 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.916567e-01 | 0.308 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.916567e-01 | 0.308 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.916567e-01 | 0.308 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.645639e-01 | 0.333 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.819213e-01 | 0.550 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.147380e-01 | 0.382 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.856518e-01 | 0.232 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 5.856518e-01 | 0.232 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.856518e-01 | 0.232 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.163566e-01 | 0.381 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.281040e-01 | 0.368 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.583056e-01 | 0.253 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.810573e-01 | 0.236 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.953302e-01 | 0.225 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 6.184823e-01 | 0.209 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.052199e-01 | 0.218 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.145470e-01 | 0.211 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.604270e-01 | 0.180 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.448844e-01 | 0.611 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.575231e-01 | 0.254 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.222153e-01 | 0.282 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.746730e-01 | 0.758 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.468465e-01 | 0.833 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.811975e-01 | 0.551 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.420213e-01 | 0.848 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.640702e-01 | 0.439 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.645639e-01 | 0.333 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.262539e-01 | 0.899 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 4.897310e-01 | 0.310 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.184128e-01 | 0.497 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.767663e-01 | 0.239 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.190002e-01 | 0.378 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.552063e-01 | 0.342 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.710610e-01 | 0.243 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.597411e-01 | 0.797 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.184823e-01 | 0.209 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.178018e-01 | 0.929 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.361769e-01 | 0.360 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.361769e-01 | 0.360 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.721404e-01 | 0.173 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.001160e-01 | 0.523 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.263441e-01 | 0.645 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.455192e-01 | 0.263 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.455192e-01 | 0.263 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.622057e-01 | 0.581 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.685026e-01 | 0.329 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.193110e-01 | 0.285 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.635131e-01 | 0.249 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.977237e-02 | 1.047 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.810573e-01 | 0.236 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.217467e-01 | 0.654 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.496123e-01 | 0.456 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.604270e-01 | 0.180 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.591037e-01 | 0.587 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.591037e-01 | 0.587 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.591037e-01 | 0.587 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.414216e-01 | 0.467 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.835338e-01 | 0.316 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.892137e-01 | 0.230 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.220570e-01 | 0.206 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.675877e-01 | 0.175 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.604270e-01 | 0.180 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.536200e-01 | 0.185 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.284795e-01 | 0.368 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.536200e-01 | 0.185 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.536200e-01 | 0.185 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.340493e-01 | 0.873 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.727974e-01 | 0.429 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 9.973637e-02 | 1.001 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.068641e-01 | 0.971 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.603172e-01 | 0.795 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.807271e-01 | 0.419 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.583056e-01 | 0.253 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.897310e-01 | 0.310 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.176821e-01 | 0.209 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.891701e-01 | 0.311 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.689242e-01 | 0.245 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.434194e-01 | 0.265 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.708730e-01 | 0.243 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.378582e-01 | 0.624 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.378582e-01 | 0.624 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.334425e-01 | 0.632 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.517530e-01 | 0.258 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.813220e-01 | 0.551 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.740716e-01 | 0.759 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.130477e-01 | 0.947 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.809580e-01 | 0.742 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.233986e-01 | 0.373 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.620703e-01 | 0.790 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.014385e-01 | 0.994 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.705357e-01 | 0.768 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.835338e-01 | 0.316 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.220145e-01 | 0.492 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.072419e-01 | 0.390 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.560289e-01 | 0.341 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.204114e-01 | 0.376 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.856518e-01 | 0.232 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.892137e-01 | 0.230 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.892137e-01 | 0.230 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.184823e-01 | 0.209 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.220570e-01 | 0.206 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.461171e-01 | 0.190 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.675877e-01 | 0.175 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.675877e-01 | 0.175 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.040179e-01 | 0.219 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.215257e-01 | 0.283 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.215257e-01 | 0.283 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.425620e-01 | 0.465 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.788752e-01 | 0.555 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.849452e-01 | 0.415 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.531218e-01 | 0.344 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.677422e-01 | 0.175 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.477486e-01 | 0.830 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.911106e-01 | 0.228 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.477486e-01 | 0.830 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.218118e-01 | 0.654 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.645639e-01 | 0.333 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.284795e-01 | 0.368 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.455192e-01 | 0.263 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.605482e-01 | 0.180 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.046861e-01 | 0.689 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.119277e-01 | 0.291 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.482148e-01 | 0.458 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.180942e-01 | 0.661 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.057085e-01 | 0.296 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.908970e-01 | 0.309 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.809580e-01 | 0.742 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.013619e-01 | 0.521 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.013619e-01 | 0.521 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.432554e-01 | 0.844 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.835338e-01 | 0.316 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.835338e-01 | 0.316 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.567502e-01 | 0.448 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 4.916567e-01 | 0.308 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.685026e-01 | 0.329 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.856518e-01 | 0.232 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.583056e-01 | 0.253 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.320313e-01 | 0.274 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.288728e-01 | 0.201 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.288728e-01 | 0.201 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.288728e-01 | 0.201 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.721404e-01 | 0.173 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.220145e-01 | 0.492 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.339863e-01 | 0.363 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.560744e-01 | 0.592 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.193110e-01 | 0.285 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.959620e-01 | 0.402 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.257730e-01 | 0.279 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.604270e-01 | 0.180 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.731220e-01 | 0.762 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.183679e-01 | 0.209 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.140705e-01 | 0.669 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.496123e-01 | 0.456 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.807079e-01 | 0.743 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.414216e-01 | 0.467 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.414216e-01 | 0.467 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.468465e-01 | 0.833 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.361769e-01 | 0.360 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.856518e-01 | 0.232 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.856518e-01 | 0.232 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.856518e-01 | 0.232 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.316657e-01 | 0.200 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.675877e-01 | 0.175 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.288728e-01 | 0.201 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.923031e-01 | 0.308 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.461171e-01 | 0.190 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.015733e-01 | 0.696 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.579176e-01 | 0.182 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.374005e-01 | 0.270 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.665754e-01 | 0.436 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.339811e-01 | 0.873 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.738646e-01 | 0.760 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.374005e-01 | 0.270 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.892137e-01 | 0.230 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.446166e-01 | 0.352 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.190002e-01 | 0.378 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.090477e-01 | 0.680 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.188600e-01 | 0.208 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.785915e-01 | 0.168 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.800335e-01 | 0.167 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.822452e-01 | 0.166 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.837217e-01 | 0.165 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.837217e-01 | 0.165 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.837217e-01 | 0.165 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.837217e-01 | 0.165 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 6.837217e-01 | 0.165 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.882252e-01 | 0.162 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.927482e-01 | 0.159 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.927482e-01 | 0.159 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.929164e-01 | 0.159 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.946757e-01 | 0.158 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.957679e-01 | 0.158 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.960664e-01 | 0.157 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.965876e-01 | 0.157 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.965876e-01 | 0.157 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.965876e-01 | 0.157 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.965876e-01 | 0.157 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.022659e-01 | 0.153 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.022659e-01 | 0.153 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.022659e-01 | 0.153 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.022659e-01 | 0.153 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.022659e-01 | 0.153 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.022659e-01 | 0.153 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.022659e-01 | 0.153 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.022659e-01 | 0.153 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.022659e-01 | 0.153 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.022659e-01 | 0.153 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.034192e-01 | 0.153 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.034192e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.034192e-01 | 0.153 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.034192e-01 | 0.153 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.034192e-01 | 0.153 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.070819e-01 | 0.151 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.080413e-01 | 0.150 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.128498e-01 | 0.147 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.176883e-01 | 0.144 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.195044e-01 | 0.143 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.195044e-01 | 0.143 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.195044e-01 | 0.143 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.195044e-01 | 0.143 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.221650e-01 | 0.141 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.221650e-01 | 0.141 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.221650e-01 | 0.141 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.278364e-01 | 0.138 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.289436e-01 | 0.137 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.291344e-01 | 0.137 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.291344e-01 | 0.137 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.333283e-01 | 0.135 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.333283e-01 | 0.135 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.333283e-01 | 0.135 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.333283e-01 | 0.135 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.333283e-01 | 0.135 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.333283e-01 | 0.135 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.333283e-01 | 0.135 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.333283e-01 | 0.135 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.333283e-01 | 0.135 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.333283e-01 | 0.135 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.358938e-01 | 0.133 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.370015e-01 | 0.133 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.399732e-01 | 0.131 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.399732e-01 | 0.131 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.399732e-01 | 0.131 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.399732e-01 | 0.131 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.403811e-01 | 0.131 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.409439e-01 | 0.130 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.409439e-01 | 0.130 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.409439e-01 | 0.130 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.409439e-01 | 0.130 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.409439e-01 | 0.130 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.511891e-01 | 0.124 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.537415e-01 | 0.123 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.568622e-01 | 0.121 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.609649e-01 | 0.119 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.609649e-01 | 0.119 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.609649e-01 | 0.119 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.609649e-01 | 0.119 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.611516e-01 | 0.119 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.611516e-01 | 0.119 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.611516e-01 | 0.119 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.611516e-01 | 0.119 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.611516e-01 | 0.119 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.611516e-01 | 0.119 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.611516e-01 | 0.119 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.611516e-01 | 0.119 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.611516e-01 | 0.119 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.611516e-01 | 0.119 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.611516e-01 | 0.119 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.611516e-01 | 0.119 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.611516e-01 | 0.119 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.644566e-01 | 0.117 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.670939e-01 | 0.115 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.696084e-01 | 0.114 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.728539e-01 | 0.112 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.728539e-01 | 0.112 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.728539e-01 | 0.112 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.731489e-01 | 0.112 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.731489e-01 | 0.112 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.759787e-01 | 0.110 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.773440e-01 | 0.109 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.796298e-01 | 0.108 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.796298e-01 | 0.108 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.796298e-01 | 0.108 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.796298e-01 | 0.108 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.810543e-01 | 0.107 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.810543e-01 | 0.107 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.822912e-01 | 0.107 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.834259e-01 | 0.106 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.834259e-01 | 0.106 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.834259e-01 | 0.106 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.854113e-01 | 0.105 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.860734e-01 | 0.105 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.860734e-01 | 0.105 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.860734e-01 | 0.105 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.860734e-01 | 0.105 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.860734e-01 | 0.105 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.860734e-01 | 0.105 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.860734e-01 | 0.105 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.860734e-01 | 0.105 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.860734e-01 | 0.105 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.860734e-01 | 0.105 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.860734e-01 | 0.105 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.860734e-01 | 0.105 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.860734e-01 | 0.105 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.860734e-01 | 0.105 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.860734e-01 | 0.105 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.860734e-01 | 0.105 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.860734e-01 | 0.105 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.884866e-01 | 0.103 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.884866e-01 | 0.103 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.884866e-01 | 0.103 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.920649e-01 | 0.101 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.920649e-01 | 0.101 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.949021e-01 | 0.100 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.967352e-01 | 0.099 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.970038e-01 | 0.099 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.970038e-01 | 0.099 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.970038e-01 | 0.099 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.000518e-01 | 0.097 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.000518e-01 | 0.097 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.000518e-01 | 0.097 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.000518e-01 | 0.097 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.022470e-01 | 0.096 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.022470e-01 | 0.096 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.022470e-01 | 0.096 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.035871e-01 | 0.095 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.044140e-01 | 0.095 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.062594e-01 | 0.094 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.071861e-01 | 0.093 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.083961e-01 | 0.092 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.083961e-01 | 0.092 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.083961e-01 | 0.092 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.083961e-01 | 0.092 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.083961e-01 | 0.092 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.083961e-01 | 0.092 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.083961e-01 | 0.092 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.091092e-01 | 0.092 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.116374e-01 | 0.091 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.130044e-01 | 0.090 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.131529e-01 | 0.090 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.131529e-01 | 0.090 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.131529e-01 | 0.090 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.131529e-01 | 0.090 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.131529e-01 | 0.090 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.131529e-01 | 0.090 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.149244e-01 | 0.089 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.157045e-01 | 0.088 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.157045e-01 | 0.088 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.157045e-01 | 0.088 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.167967e-01 | 0.088 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.191793e-01 | 0.087 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.195607e-01 | 0.086 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.216786e-01 | 0.085 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.230082e-01 | 0.085 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.253144e-01 | 0.083 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.281434e-01 | 0.082 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.281434e-01 | 0.082 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.281434e-01 | 0.082 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.283761e-01 | 0.082 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.283761e-01 | 0.082 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.283761e-01 | 0.082 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.283907e-01 | 0.082 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.283907e-01 | 0.082 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.283907e-01 | 0.082 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.283907e-01 | 0.082 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.283907e-01 | 0.082 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.283907e-01 | 0.082 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.283907e-01 | 0.082 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.283907e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.283907e-01 | 0.082 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.283907e-01 | 0.082 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.309860e-01 | 0.080 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.314722e-01 | 0.080 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.317627e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.317627e-01 | 0.080 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.339540e-01 | 0.079 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.339540e-01 | 0.079 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.357238e-01 | 0.078 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.402930e-01 | 0.076 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.402930e-01 | 0.076 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.402930e-01 | 0.076 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.408218e-01 | 0.075 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.408218e-01 | 0.075 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.420413e-01 | 0.075 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.420413e-01 | 0.075 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.420413e-01 | 0.075 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.435788e-01 | 0.074 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.443286e-01 | 0.073 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.462999e-01 | 0.072 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.462999e-01 | 0.072 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.462999e-01 | 0.072 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.462999e-01 | 0.072 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.462999e-01 | 0.072 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.462999e-01 | 0.072 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.462999e-01 | 0.072 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.462999e-01 | 0.072 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.462999e-01 | 0.072 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.462999e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.497255e-01 | 0.071 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.497255e-01 | 0.071 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.514870e-01 | 0.070 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.514870e-01 | 0.070 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.514870e-01 | 0.070 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.540772e-01 | 0.069 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.541513e-01 | 0.068 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.541513e-01 | 0.068 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.549114e-01 | 0.068 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.549114e-01 | 0.068 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.575419e-01 | 0.067 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.575419e-01 | 0.067 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.592477e-01 | 0.066 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.619903e-01 | 0.064 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.623409e-01 | 0.064 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.623409e-01 | 0.064 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.623409e-01 | 0.064 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.623409e-01 | 0.064 | 1 | 1 |
| HDL assembly | R-HSA-8963896 | 8.623409e-01 | 0.064 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.623409e-01 | 0.064 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.623409e-01 | 0.064 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.639571e-01 | 0.064 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.642178e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.642178e-01 | 0.063 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.652193e-01 | 0.063 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.653440e-01 | 0.063 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.653440e-01 | 0.063 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.658623e-01 | 0.063 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.668166e-01 | 0.062 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.668166e-01 | 0.062 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.668166e-01 | 0.062 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.668166e-01 | 0.062 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.670077e-01 | 0.062 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.686479e-01 | 0.061 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.718350e-01 | 0.060 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.718350e-01 | 0.060 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.722210e-01 | 0.059 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.722210e-01 | 0.059 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.723878e-01 | 0.059 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.727178e-01 | 0.059 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.727880e-01 | 0.059 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.754009e-01 | 0.058 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.767087e-01 | 0.057 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.767087e-01 | 0.057 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.767087e-01 | 0.057 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.767087e-01 | 0.057 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.767087e-01 | 0.057 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.767087e-01 | 0.057 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.767087e-01 | 0.057 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.767087e-01 | 0.057 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.767087e-01 | 0.057 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.767087e-01 | 0.057 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.767087e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.767087e-01 | 0.057 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.767087e-01 | 0.057 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.778183e-01 | 0.057 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.778183e-01 | 0.057 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.785245e-01 | 0.056 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.798848e-01 | 0.056 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.798848e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.805086e-01 | 0.055 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.810531e-01 | 0.055 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.810531e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.813037e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.813037e-01 | 0.055 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.828690e-01 | 0.054 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.843935e-01 | 0.053 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.843935e-01 | 0.053 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.846137e-01 | 0.053 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.879751e-01 | 0.052 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.879751e-01 | 0.052 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.895777e-01 | 0.051 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.895777e-01 | 0.051 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.895777e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.895777e-01 | 0.051 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.895777e-01 | 0.051 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.895777e-01 | 0.051 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.895777e-01 | 0.051 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.895777e-01 | 0.051 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.895777e-01 | 0.051 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.896760e-01 | 0.051 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.896760e-01 | 0.051 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.899507e-01 | 0.051 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.916948e-01 | 0.050 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.930804e-01 | 0.049 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.955785e-01 | 0.048 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.956907e-01 | 0.048 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.958722e-01 | 0.048 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.973437e-01 | 0.047 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.973437e-01 | 0.047 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.973437e-01 | 0.047 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.011040e-01 | 0.045 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.011040e-01 | 0.045 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.011040e-01 | 0.045 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.011040e-01 | 0.045 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.011040e-01 | 0.045 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.011040e-01 | 0.045 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.011040e-01 | 0.045 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.011040e-01 | 0.045 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.011040e-01 | 0.045 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.011040e-01 | 0.045 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.025778e-01 | 0.045 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.025778e-01 | 0.045 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.030131e-01 | 0.044 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.037810e-01 | 0.044 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.052591e-01 | 0.043 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.052591e-01 | 0.043 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.052591e-01 | 0.043 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.059779e-01 | 0.043 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.059779e-01 | 0.043 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.091495e-01 | 0.041 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.091495e-01 | 0.041 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.091495e-01 | 0.041 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.100831e-01 | 0.041 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.103863e-01 | 0.041 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.114278e-01 | 0.040 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.114278e-01 | 0.040 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.114278e-01 | 0.040 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.114278e-01 | 0.040 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.114278e-01 | 0.040 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.114278e-01 | 0.040 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.114278e-01 | 0.040 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.122789e-01 | 0.040 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.122789e-01 | 0.040 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.122789e-01 | 0.040 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.122789e-01 | 0.040 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.125106e-01 | 0.040 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.191512e-01 | 0.037 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.192375e-01 | 0.037 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.192375e-01 | 0.037 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.206745e-01 | 0.036 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.206745e-01 | 0.036 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.206745e-01 | 0.036 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.206745e-01 | 0.036 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.206745e-01 | 0.036 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.206745e-01 | 0.036 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.206745e-01 | 0.036 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.206745e-01 | 0.036 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.206745e-01 | 0.036 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.210419e-01 | 0.036 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.212449e-01 | 0.036 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.212449e-01 | 0.036 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.212449e-01 | 0.036 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.240839e-01 | 0.034 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.249174e-01 | 0.034 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.289563e-01 | 0.032 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.289563e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.289563e-01 | 0.032 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.289563e-01 | 0.032 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.289563e-01 | 0.032 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.289563e-01 | 0.032 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.289563e-01 | 0.032 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.289563e-01 | 0.032 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.299484e-01 | 0.032 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.305900e-01 | 0.031 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.305900e-01 | 0.031 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.309902e-01 | 0.031 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.309902e-01 | 0.031 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.315181e-01 | 0.031 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.327565e-01 | 0.030 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.336411e-01 | 0.030 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.341538e-01 | 0.030 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.341538e-01 | 0.030 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.341538e-01 | 0.030 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.358656e-01 | 0.029 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.358656e-01 | 0.029 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.362700e-01 | 0.029 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.363478e-01 | 0.029 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.363739e-01 | 0.029 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.363739e-01 | 0.029 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.363739e-01 | 0.029 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.363739e-01 | 0.029 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.363739e-01 | 0.029 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.386510e-01 | 0.027 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.386619e-01 | 0.027 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.386619e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.397854e-01 | 0.027 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.407687e-01 | 0.027 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.416323e-01 | 0.026 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.419617e-01 | 0.026 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.430174e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.430174e-01 | 0.025 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.430174e-01 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.448857e-01 | 0.025 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.450396e-01 | 0.025 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.453223e-01 | 0.024 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.463730e-01 | 0.024 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.464155e-01 | 0.024 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.476694e-01 | 0.023 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.489676e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.489676e-01 | 0.023 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.489676e-01 | 0.023 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.489676e-01 | 0.023 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.489676e-01 | 0.023 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.495487e-01 | 0.022 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.498176e-01 | 0.022 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.498176e-01 | 0.022 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.498176e-01 | 0.022 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.524235e-01 | 0.021 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.541974e-01 | 0.020 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.541974e-01 | 0.020 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.542968e-01 | 0.020 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.542968e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.542968e-01 | 0.020 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.542968e-01 | 0.020 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.542968e-01 | 0.020 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.542968e-01 | 0.020 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.542968e-01 | 0.020 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.547279e-01 | 0.020 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.549742e-01 | 0.020 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.555264e-01 | 0.020 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.558257e-01 | 0.020 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.569748e-01 | 0.019 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.570320e-01 | 0.019 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.571028e-01 | 0.019 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.571028e-01 | 0.019 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.580836e-01 | 0.019 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.582100e-01 | 0.019 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.582100e-01 | 0.019 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.590698e-01 | 0.018 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.590698e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.590698e-01 | 0.018 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.590698e-01 | 0.018 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.590698e-01 | 0.018 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.604694e-01 | 0.018 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.606118e-01 | 0.017 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.618844e-01 | 0.017 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.618844e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.619657e-01 | 0.017 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.620929e-01 | 0.017 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.623206e-01 | 0.017 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.623206e-01 | 0.017 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.624326e-01 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.633445e-01 | 0.016 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.633445e-01 | 0.016 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.633445e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.633445e-01 | 0.016 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.633445e-01 | 0.016 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.635865e-01 | 0.016 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.635865e-01 | 0.016 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.652474e-01 | 0.015 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.652474e-01 | 0.015 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.652474e-01 | 0.015 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.652474e-01 | 0.015 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.667111e-01 | 0.015 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.671730e-01 | 0.014 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.671730e-01 | 0.014 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.671730e-01 | 0.014 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.671730e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.671730e-01 | 0.014 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.671730e-01 | 0.014 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.671730e-01 | 0.014 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.683240e-01 | 0.014 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.683240e-01 | 0.014 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.683240e-01 | 0.014 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.691389e-01 | 0.014 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.691389e-01 | 0.014 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.697056e-01 | 0.013 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.698200e-01 | 0.013 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.702351e-01 | 0.013 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.703243e-01 | 0.013 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.706019e-01 | 0.013 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.706019e-01 | 0.013 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.711373e-01 | 0.013 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.711373e-01 | 0.013 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.711373e-01 | 0.013 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.711373e-01 | 0.013 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.716051e-01 | 0.013 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.716051e-01 | 0.013 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.736727e-01 | 0.012 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.736727e-01 | 0.012 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.736727e-01 | 0.012 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.736727e-01 | 0.012 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.736727e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.736727e-01 | 0.012 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.736727e-01 | 0.012 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.736727e-01 | 0.012 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.736727e-01 | 0.012 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.737087e-01 | 0.012 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.737087e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.737087e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.738837e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.740193e-01 | 0.011 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.752626e-01 | 0.011 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.752956e-01 | 0.011 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.759881e-01 | 0.011 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.759973e-01 | 0.011 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.760581e-01 | 0.011 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.760581e-01 | 0.011 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.764230e-01 | 0.010 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.764230e-01 | 0.010 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.764230e-01 | 0.010 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.764230e-01 | 0.010 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.777514e-01 | 0.010 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.779305e-01 | 0.010 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.779731e-01 | 0.010 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.779731e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.779731e-01 | 0.010 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.782036e-01 | 0.010 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.782036e-01 | 0.010 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.785410e-01 | 0.009 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.788861e-01 | 0.009 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.788861e-01 | 0.009 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.788861e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.788861e-01 | 0.009 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.788861e-01 | 0.009 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.788861e-01 | 0.009 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.792238e-01 | 0.009 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.794223e-01 | 0.009 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.794223e-01 | 0.009 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.797226e-01 | 0.009 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.797226e-01 | 0.009 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.801624e-01 | 0.009 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.809743e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.810920e-01 | 0.008 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.810920e-01 | 0.008 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.813753e-01 | 0.008 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.816952e-01 | 0.008 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.819500e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.819500e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.826872e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.828989e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.830676e-01 | 0.007 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.835807e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.835807e-01 | 0.007 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.840412e-01 | 0.007 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.840760e-01 | 0.007 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.843977e-01 | 0.007 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.848368e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.849927e-01 | 0.007 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.853571e-01 | 0.006 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.864213e-01 | 0.006 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.864213e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.864213e-01 | 0.006 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.864235e-01 | 0.006 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.865794e-01 | 0.006 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.868738e-01 | 0.006 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.872806e-01 | 0.006 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.876591e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.878403e-01 | 0.005 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.888899e-01 | 0.005 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.890234e-01 | 0.005 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.891111e-01 | 0.005 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.891111e-01 | 0.005 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.891111e-01 | 0.005 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.891111e-01 | 0.005 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.891111e-01 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.891111e-01 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.891111e-01 | 0.005 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.893203e-01 | 0.005 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.898100e-01 | 0.004 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.898100e-01 | 0.004 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.902458e-01 | 0.004 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.902491e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.902491e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.902491e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.902491e-01 | 0.004 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.907436e-01 | 0.004 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.908454e-01 | 0.004 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.912683e-01 | 0.004 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.912683e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.912683e-01 | 0.004 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.912683e-01 | 0.004 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.912752e-01 | 0.004 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.914522e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.914522e-01 | 0.004 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.917520e-01 | 0.004 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.918764e-01 | 0.004 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.920903e-01 | 0.003 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.921810e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.921810e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.921810e-01 | 0.003 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.922147e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.929983e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.937302e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.937302e-01 | 0.003 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.941946e-01 | 0.003 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.943857e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.943857e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.947972e-01 | 0.002 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.949727e-01 | 0.002 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.949727e-01 | 0.002 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.949727e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.953021e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.954050e-01 | 0.002 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.954983e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.954983e-01 | 0.002 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.955586e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.957988e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.957988e-01 | 0.002 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.958477e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.959690e-01 | 0.002 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.963906e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.964965e-01 | 0.002 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.967680e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.967680e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.967680e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.967680e-01 | 0.001 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.968703e-01 | 0.001 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.968703e-01 | 0.001 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.971060e-01 | 0.001 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.971060e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.971060e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.973248e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.973477e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.976361e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.976797e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.977334e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.977640e-01 | 0.001 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.978583e-01 | 0.001 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.978735e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.979224e-01 | 0.001 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.979224e-01 | 0.001 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.979224e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.979644e-01 | 0.001 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.981208e-01 | 0.001 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.981398e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.981398e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.981398e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.981398e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.982551e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.982667e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.984088e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.984088e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.984933e-01 | 0.001 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.984960e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.985086e-01 | 0.001 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.985086e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.985086e-01 | 0.001 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.986123e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.986123e-01 | 0.001 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.986646e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.986956e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.987139e-01 | 0.001 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.987253e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.987537e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.989295e-01 | 0.000 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.989310e-01 | 0.000 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.989312e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.989532e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.989735e-01 | 0.000 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.990027e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.990257e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.990257e-01 | 0.000 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.990354e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.990415e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.991121e-01 | 0.000 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.991418e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.991418e-01 | 0.000 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.992081e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.992081e-01 | 0.000 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.992316e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.992316e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.992630e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.992836e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.993120e-01 | 0.000 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.993165e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.993840e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.993886e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.994429e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.994485e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.994485e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995062e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.995093e-01 | 0.000 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.995579e-01 | 0.000 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.995749e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.996061e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.996061e-01 | 0.000 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.996094e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.996116e-01 | 0.000 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.996178e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.996457e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.996457e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.996457e-01 | 0.000 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.996828e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.997025e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997106e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.997385e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.997385e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997457e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997457e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.997457e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.997524e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997723e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.997778e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.998032e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.998071e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.998211e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.998347e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998366e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.998426e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.998654e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.998654e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.998716e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.998913e-01 | 0.000 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.998950e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998951e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998951e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.998953e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.998953e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998974e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999054e-01 | 0.000 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.999061e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999085e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999229e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999247e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.999247e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999271e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999326e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.999343e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.999372e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999433e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999460e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999460e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999538e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.999722e-01 | 0.000 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.999751e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999775e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999844e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999883e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999902e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.999904e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999908e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999911e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.999918e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999918e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999926e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.999941e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999941e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999947e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999960e-01 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.999964e-01 | 0.000 | 1 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999969e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999983e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999984e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.999985e-01 | 0.000 | 1 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999985e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999985e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999988e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999989e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999993e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999995e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999997e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999998e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 1 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 1 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.862972e-08 | 7.052 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.278026e-08 | 7.369 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.129686e-08 | 7.213 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.066885e-07 | 6.972 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.055187e-08 | 7.094 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.201741e-07 | 6.143 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.247089e-06 | 5.904 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.830990e-06 | 5.737 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.450145e-06 | 5.611 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.254288e-06 | 5.488 | 1 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.068485e-06 | 5.391 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.043595e-06 | 5.297 | 1 | 1 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.265635e-06 | 5.279 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.987835e-06 | 5.156 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.019548e-05 | 4.992 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.897058e-05 | 4.722 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.069236e-05 | 4.684 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.006827e-05 | 4.522 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.286608e-05 | 4.483 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.768862e-05 | 4.169 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.829045e-05 | 4.106 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.609287e-05 | 4.065 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.609287e-05 | 4.065 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.197429e-04 | 3.922 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.824135e-04 | 3.739 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.808529e-04 | 3.743 | 1 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.172182e-04 | 3.663 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.024087e-04 | 3.519 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.071820e-04 | 3.513 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.185526e-04 | 3.497 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.948079e-04 | 3.404 | 1 | 1 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.368903e-04 | 3.360 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.829313e-04 | 3.316 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.196549e-04 | 3.284 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.265152e-04 | 3.279 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.086747e-04 | 3.216 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.209265e-04 | 3.142 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.995756e-04 | 3.097 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.995756e-04 | 3.097 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.995756e-04 | 3.097 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.462588e-04 | 3.072 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.801463e-04 | 3.009 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.801463e-04 | 3.009 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.783598e-04 | 3.010 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.878107e-04 | 3.005 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.062390e-03 | 2.974 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.062390e-03 | 2.974 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.062390e-03 | 2.974 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.878107e-04 | 3.005 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.402561e-03 | 2.853 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.441706e-03 | 2.841 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.441706e-03 | 2.841 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.482939e-03 | 2.829 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.547623e-03 | 2.810 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.666975e-03 | 2.778 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.691379e-03 | 2.772 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.731207e-03 | 2.762 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.731207e-03 | 2.762 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.805979e-03 | 2.743 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.825635e-03 | 2.739 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.927452e-03 | 2.715 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.902450e-03 | 2.721 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.927452e-03 | 2.715 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.050120e-03 | 2.688 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.179535e-03 | 2.662 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.066013e-03 | 2.685 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.451095e-03 | 2.611 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.614883e-03 | 2.583 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.618768e-03 | 2.582 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.875337e-03 | 2.541 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.066209e-03 | 2.513 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.246347e-03 | 2.489 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.393304e-03 | 2.469 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.638892e-03 | 2.439 | 1 | 1 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.196938e-03 | 2.377 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.222918e-03 | 2.374 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.222918e-03 | 2.374 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.961666e-03 | 2.402 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.286686e-03 | 2.368 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.492052e-03 | 2.348 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.602739e-03 | 2.337 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.813204e-03 | 2.318 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.822200e-03 | 2.317 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.233428e-03 | 2.281 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.322687e-03 | 2.274 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.322687e-03 | 2.274 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.502465e-03 | 2.259 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.525933e-03 | 2.258 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.682318e-03 | 2.245 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.821014e-03 | 2.235 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.997839e-03 | 2.222 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.127852e-03 | 2.213 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.356965e-03 | 2.197 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.459534e-03 | 2.190 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.843624e-03 | 2.165 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.362471e-03 | 2.133 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.524017e-03 | 2.124 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.909019e-03 | 2.102 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 7.909019e-03 | 2.102 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.047965e-03 | 2.043 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 9.047965e-03 | 2.043 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.247341e-03 | 2.034 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.581843e-03 | 2.019 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 9.978367e-03 | 2.001 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 9.978367e-03 | 2.001 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 9.978367e-03 | 2.001 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.119181e-02 | 1.951 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.109097e-02 | 1.955 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.097001e-02 | 1.960 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.138415e-02 | 1.944 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.150203e-02 | 1.939 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.166337e-02 | 1.933 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.289018e-02 | 1.890 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.245187e-02 | 1.905 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.267224e-02 | 1.897 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.267224e-02 | 1.897 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.267279e-02 | 1.897 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.311987e-02 | 1.882 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.267224e-02 | 1.897 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.245187e-02 | 1.905 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.311987e-02 | 1.882 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.293506e-02 | 1.888 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.313300e-02 | 1.882 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.313300e-02 | 1.882 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.376204e-02 | 1.861 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.457758e-02 | 1.836 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.457758e-02 | 1.836 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.581931e-02 | 1.801 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.581931e-02 | 1.801 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.691729e-02 | 1.772 | 1 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.646617e-02 | 1.783 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.658005e-02 | 1.780 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.679682e-02 | 1.775 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.659858e-02 | 1.780 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.578810e-02 | 1.802 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.830253e-02 | 1.737 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.837648e-02 | 1.736 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.931090e-02 | 1.714 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.931090e-02 | 1.714 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.001305e-02 | 1.699 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.101134e-02 | 1.678 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.147416e-02 | 1.668 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.147416e-02 | 1.668 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.358369e-02 | 1.627 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.329275e-02 | 1.633 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.329275e-02 | 1.633 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.329275e-02 | 1.633 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.329275e-02 | 1.633 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.329275e-02 | 1.633 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.455964e-02 | 1.610 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.424791e-02 | 1.615 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.237321e-02 | 1.650 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.569209e-02 | 1.590 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.571354e-02 | 1.590 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.606012e-02 | 1.584 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.710418e-02 | 1.567 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.720158e-02 | 1.565 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.720158e-02 | 1.565 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.763828e-02 | 1.558 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.789450e-02 | 1.554 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.789450e-02 | 1.554 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.824754e-02 | 1.549 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.824754e-02 | 1.549 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.869169e-02 | 1.542 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.882942e-02 | 1.540 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.913847e-02 | 1.536 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.345726e-02 | 1.476 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.030908e-02 | 1.518 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.254333e-02 | 1.488 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.030908e-02 | 1.518 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.221275e-02 | 1.492 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.281626e-02 | 1.484 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.367684e-02 | 1.473 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.478309e-02 | 1.459 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.546826e-02 | 1.450 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.655787e-02 | 1.437 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.655787e-02 | 1.437 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.666276e-02 | 1.436 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.712440e-02 | 1.430 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.801096e-02 | 1.420 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.050927e-02 | 1.392 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.144979e-02 | 1.382 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.734757e-02 | 1.325 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.734757e-02 | 1.325 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.101948e-02 | 1.387 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.594421e-02 | 1.338 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.594421e-02 | 1.338 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.437137e-02 | 1.353 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.276943e-02 | 1.369 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.144979e-02 | 1.382 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.101948e-02 | 1.387 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.643131e-02 | 1.333 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.734757e-02 | 1.325 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.188818e-02 | 1.378 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.690036e-02 | 1.329 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.643131e-02 | 1.333 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.643131e-02 | 1.333 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.081174e-02 | 1.294 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.081174e-02 | 1.294 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.181108e-02 | 1.286 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.820466e-02 | 1.235 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.951639e-02 | 1.225 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.951639e-02 | 1.225 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.951639e-02 | 1.225 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.951639e-02 | 1.225 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.046148e-02 | 1.219 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.204207e-02 | 1.207 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.517337e-02 | 1.186 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.517337e-02 | 1.186 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.687219e-02 | 1.114 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.802962e-02 | 1.167 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.802962e-02 | 1.167 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.865248e-02 | 1.104 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.282673e-02 | 1.138 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.508317e-02 | 1.124 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.294065e-02 | 1.137 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.966395e-02 | 1.157 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.922751e-02 | 1.101 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.803764e-02 | 1.167 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.299293e-02 | 1.137 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.759671e-02 | 1.170 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.036944e-02 | 1.095 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.019016e-02 | 1.154 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.667531e-02 | 1.115 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.028571e-02 | 1.153 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.299293e-02 | 1.137 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.802962e-02 | 1.167 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.802962e-02 | 1.167 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.574161e-02 | 1.121 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.803764e-02 | 1.167 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.803764e-02 | 1.167 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.747111e-02 | 1.111 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.145009e-02 | 1.089 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.211358e-02 | 1.086 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 8.414523e-02 | 1.075 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.414523e-02 | 1.075 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.414523e-02 | 1.075 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.452289e-02 | 1.073 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.587509e-02 | 1.066 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.587509e-02 | 1.066 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.769300e-02 | 1.057 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.770605e-02 | 1.057 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.800620e-02 | 1.055 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.957356e-02 | 1.048 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.004766e-02 | 1.046 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.004766e-02 | 1.046 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.004766e-02 | 1.046 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.088499e-01 | 0.963 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.088499e-01 | 0.963 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.088499e-01 | 0.963 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.088499e-01 | 0.963 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.088499e-01 | 0.963 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.035231e-01 | 0.985 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.035231e-01 | 0.985 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.562537e-02 | 1.019 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.000898e-01 | 1.000 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.021843e-01 | 0.991 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.025938e-01 | 0.989 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.025938e-01 | 0.989 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.025938e-01 | 0.989 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 1.035231e-01 | 0.985 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.021902e-01 | 0.991 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.199048e-02 | 1.036 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.618524e-02 | 1.017 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.088499e-01 | 0.963 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.007041e-01 | 0.997 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.111416e-01 | 0.954 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 1.021843e-01 | 0.991 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.562537e-02 | 1.019 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.050849e-01 | 0.978 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.879453e-02 | 1.005 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.131950e-01 | 0.946 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.119682e-01 | 0.951 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.618524e-02 | 1.017 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.033225e-01 | 0.986 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.088499e-01 | 0.963 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.093061e-01 | 0.961 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.143960e-01 | 0.942 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.150268e-01 | 0.939 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.150268e-01 | 0.939 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.150268e-01 | 0.939 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.150268e-01 | 0.939 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.150268e-01 | 0.939 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.150268e-01 | 0.939 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.167168e-01 | 0.933 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.167168e-01 | 0.933 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.478393e-01 | 0.830 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.478393e-01 | 0.830 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.478393e-01 | 0.830 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.351700e-01 | 0.869 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.203835e-01 | 0.919 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.203835e-01 | 0.919 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.381709e-01 | 0.860 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.381709e-01 | 0.860 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.381709e-01 | 0.860 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.381709e-01 | 0.860 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.381709e-01 | 0.860 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.381709e-01 | 0.860 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.381709e-01 | 0.860 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.567802e-01 | 0.805 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.285359e-01 | 0.891 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.285359e-01 | 0.891 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.573812e-01 | 0.803 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.280212e-01 | 0.893 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.280212e-01 | 0.893 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.398032e-01 | 0.854 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.398032e-01 | 0.854 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.398032e-01 | 0.854 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.342082e-01 | 0.872 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.461662e-01 | 0.835 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.387354e-01 | 0.858 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.387354e-01 | 0.858 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.381709e-01 | 0.860 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.461662e-01 | 0.835 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.461662e-01 | 0.835 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.319233e-01 | 0.880 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.461662e-01 | 0.835 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.446836e-01 | 0.840 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.203835e-01 | 0.919 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.483063e-01 | 0.829 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.319233e-01 | 0.880 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.478393e-01 | 0.830 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.520392e-01 | 0.818 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.241078e-01 | 0.906 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.373598e-01 | 0.862 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.342082e-01 | 0.872 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.285359e-01 | 0.891 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.187628e-01 | 0.925 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.519643e-01 | 0.818 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.351700e-01 | 0.869 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.440204e-01 | 0.842 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.542348e-01 | 0.812 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.526462e-01 | 0.816 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.190650e-01 | 0.924 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.492056e-01 | 0.826 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.280212e-01 | 0.893 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.567802e-01 | 0.805 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.547877e-01 | 0.810 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.573812e-01 | 0.803 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.605303e-01 | 0.794 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.605303e-01 | 0.794 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.627117e-01 | 0.789 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.643310e-01 | 0.784 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.647040e-01 | 0.783 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.647040e-01 | 0.783 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.648845e-01 | 0.783 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.654423e-01 | 0.781 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.691119e-01 | 0.772 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 1.714426e-01 | 0.766 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.719695e-01 | 0.765 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.726256e-01 | 0.763 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.726256e-01 | 0.763 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.754852e-01 | 0.756 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.761067e-01 | 0.754 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.782062e-01 | 0.749 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.782062e-01 | 0.749 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.133546e-01 | 0.671 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.133546e-01 | 0.671 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.133546e-01 | 0.671 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.133546e-01 | 0.671 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.133546e-01 | 0.671 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.738365e-01 | 0.563 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.738365e-01 | 0.563 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.738365e-01 | 0.563 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.738365e-01 | 0.563 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.738365e-01 | 0.563 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.738365e-01 | 0.563 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.911319e-01 | 0.719 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.911319e-01 | 0.719 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.911319e-01 | 0.719 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.911319e-01 | 0.719 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.296716e-01 | 0.482 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.296716e-01 | 0.482 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.296716e-01 | 0.482 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.296716e-01 | 0.482 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.296716e-01 | 0.482 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.201333e-01 | 0.657 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.494587e-01 | 0.603 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.494587e-01 | 0.603 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.494587e-01 | 0.603 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.812166e-01 | 0.419 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 3.812166e-01 | 0.419 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.812166e-01 | 0.419 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 3.812166e-01 | 0.419 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.812166e-01 | 0.419 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.812166e-01 | 0.419 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.960468e-01 | 0.708 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.960468e-01 | 0.708 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.788871e-01 | 0.555 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.788871e-01 | 0.555 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.788871e-01 | 0.555 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.165001e-01 | 0.665 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.165001e-01 | 0.665 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.082296e-01 | 0.511 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.082296e-01 | 0.511 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.082296e-01 | 0.511 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.082296e-01 | 0.511 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.082296e-01 | 0.511 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.082296e-01 | 0.511 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.082296e-01 | 0.511 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.288009e-01 | 0.368 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.660396e-01 | 0.436 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.660396e-01 | 0.436 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.660396e-01 | 0.436 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.727285e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 4.727285e-01 | 0.325 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 4.727285e-01 | 0.325 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.727285e-01 | 0.325 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.727285e-01 | 0.325 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.727285e-01 | 0.325 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.727285e-01 | 0.325 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.727285e-01 | 0.325 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 4.727285e-01 | 0.325 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 4.727285e-01 | 0.325 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.021304e-01 | 0.694 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.021304e-01 | 0.694 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.021304e-01 | 0.694 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.021304e-01 | 0.694 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.145097e-01 | 0.669 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.232226e-01 | 0.490 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.271408e-01 | 0.644 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.901444e-01 | 0.537 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.901444e-01 | 0.537 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.087567e-01 | 0.680 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.448785e-01 | 0.462 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.448785e-01 | 0.462 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.200557e-01 | 0.657 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.078979e-01 | 0.512 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.078979e-01 | 0.512 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.530776e-01 | 0.597 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.663422e-01 | 0.575 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.664699e-01 | 0.436 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.664699e-01 | 0.436 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.664699e-01 | 0.436 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.664699e-01 | 0.436 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.218886e-01 | 0.375 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.132804e-01 | 0.290 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.132804e-01 | 0.290 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.132804e-01 | 0.290 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.241866e-01 | 0.489 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.488539e-01 | 0.348 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.488539e-01 | 0.348 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.092197e-01 | 0.388 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.092197e-01 | 0.388 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.302717e-01 | 0.366 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.507157e-01 | 0.259 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.507157e-01 | 0.259 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.239511e-01 | 0.490 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.421659e-01 | 0.466 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.421659e-01 | 0.466 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.627937e-01 | 0.440 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.291875e-01 | 0.640 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.768448e-01 | 0.424 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.474938e-01 | 0.459 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.005586e-01 | 0.301 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.806423e-01 | 0.419 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.049597e-01 | 0.393 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.736896e-01 | 0.427 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.487899e-01 | 0.348 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.916060e-01 | 0.308 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.252141e-01 | 0.280 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.774284e-01 | 0.423 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.576394e-01 | 0.339 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.490337e-01 | 0.260 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.306293e-01 | 0.275 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.238500e-01 | 0.281 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.494993e-01 | 0.260 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.383406e-01 | 0.269 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.445070e-01 | 0.264 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.324409e-01 | 0.634 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.241866e-01 | 0.489 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.616125e-01 | 0.442 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.334946e-01 | 0.632 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.625350e-01 | 0.441 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.320930e-01 | 0.364 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.306293e-01 | 0.275 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.071257e-01 | 0.684 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.444483e-01 | 0.352 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.460162e-01 | 0.609 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.241866e-01 | 0.489 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.795344e-01 | 0.421 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.507157e-01 | 0.259 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.241866e-01 | 0.489 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.494993e-01 | 0.260 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.210665e-01 | 0.655 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.917594e-01 | 0.535 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.021304e-01 | 0.694 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.078979e-01 | 0.512 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.329739e-01 | 0.364 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.383406e-01 | 0.269 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.400036e-01 | 0.620 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.400036e-01 | 0.620 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.373694e-01 | 0.625 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.178652e-01 | 0.379 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.257549e-01 | 0.487 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.788871e-01 | 0.555 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.788871e-01 | 0.555 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.727285e-01 | 0.325 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.087018e-01 | 0.510 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.750931e-01 | 0.323 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.667273e-01 | 0.574 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.490337e-01 | 0.260 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.881834e-01 | 0.311 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.974027e-01 | 0.401 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.503548e-01 | 0.346 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.000477e-01 | 0.699 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.042196e-01 | 0.517 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.494587e-01 | 0.603 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.494587e-01 | 0.603 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.812166e-01 | 0.419 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.288009e-01 | 0.368 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.373256e-01 | 0.472 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.660396e-01 | 0.436 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.727285e-01 | 0.325 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.315657e-01 | 0.635 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.795344e-01 | 0.421 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.579963e-01 | 0.588 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.507157e-01 | 0.259 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.507157e-01 | 0.259 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.136996e-01 | 0.670 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.490337e-01 | 0.260 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.200557e-01 | 0.657 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.007142e-01 | 0.522 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.494993e-01 | 0.260 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.078979e-01 | 0.512 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.549523e-01 | 0.450 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.025666e-01 | 0.519 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.912125e-01 | 0.718 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.935170e-01 | 0.405 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.503548e-01 | 0.346 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.630998e-01 | 0.580 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.911319e-01 | 0.719 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.201333e-01 | 0.657 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.082296e-01 | 0.511 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.288009e-01 | 0.368 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.373256e-01 | 0.472 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.799893e-01 | 0.553 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.660396e-01 | 0.436 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.750931e-01 | 0.323 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.750931e-01 | 0.323 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.184686e-01 | 0.497 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.005586e-01 | 0.301 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.433967e-01 | 0.464 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.087567e-01 | 0.680 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.677826e-01 | 0.434 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 3.942584e-01 | 0.404 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.167843e-01 | 0.499 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.942584e-01 | 0.404 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.888695e-01 | 0.539 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.551253e-01 | 0.593 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.917594e-01 | 0.535 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.507157e-01 | 0.259 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.252141e-01 | 0.280 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.974027e-01 | 0.401 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.373256e-01 | 0.472 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.797764e-01 | 0.553 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.397522e-01 | 0.469 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.766180e-01 | 0.424 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.210665e-01 | 0.655 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.054254e-01 | 0.687 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.054254e-01 | 0.687 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.014002e-01 | 0.300 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.015688e-01 | 0.521 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.750931e-01 | 0.323 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.783062e-01 | 0.320 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.078281e-01 | 0.682 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.133546e-01 | 0.671 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.738365e-01 | 0.563 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.738365e-01 | 0.563 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.738365e-01 | 0.563 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.296716e-01 | 0.482 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.201333e-01 | 0.657 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.494587e-01 | 0.603 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.812166e-01 | 0.419 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.960468e-01 | 0.708 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.082296e-01 | 0.511 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 4.288009e-01 | 0.368 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.373256e-01 | 0.472 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.373256e-01 | 0.472 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.373256e-01 | 0.472 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 4.727285e-01 | 0.325 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.727285e-01 | 0.325 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.942584e-01 | 0.404 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.302717e-01 | 0.366 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.356260e-01 | 0.474 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.113238e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.490337e-01 | 0.260 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.183820e-01 | 0.285 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.238500e-01 | 0.281 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.849850e-01 | 0.415 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.799893e-01 | 0.553 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.328438e-01 | 0.364 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.651744e-01 | 0.576 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.042196e-01 | 0.517 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 2.494587e-01 | 0.603 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.585619e-01 | 0.587 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.005586e-01 | 0.301 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.347729e-01 | 0.272 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.931212e-01 | 0.405 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.288009e-01 | 0.368 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.795344e-01 | 0.421 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.151832e-01 | 0.382 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.510464e-01 | 0.346 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.576394e-01 | 0.339 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.576394e-01 | 0.339 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.844579e-01 | 0.415 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.960468e-01 | 0.708 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.490337e-01 | 0.260 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.044082e-01 | 0.297 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.948943e-01 | 0.710 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 3.812166e-01 | 0.419 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.788871e-01 | 0.555 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.883540e-01 | 0.725 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.727285e-01 | 0.325 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.507157e-01 | 0.259 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.070661e-01 | 0.390 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.130574e-01 | 0.504 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.449249e-01 | 0.462 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.016401e-01 | 0.300 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.493575e-01 | 0.260 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.183820e-01 | 0.285 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.183820e-01 | 0.285 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.187103e-01 | 0.285 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.660396e-01 | 0.436 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.329739e-01 | 0.364 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.344989e-01 | 0.630 | 1 | 1 |
| MAP kinase activation | R-HSA-450294 | 4.745208e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.553712e-01 | 0.449 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.296716e-01 | 0.482 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.296716e-01 | 0.482 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.812166e-01 | 0.419 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.373256e-01 | 0.472 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.727285e-01 | 0.325 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.507157e-01 | 0.259 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 5.507157e-01 | 0.259 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.507157e-01 | 0.259 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.916060e-01 | 0.308 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.252141e-01 | 0.280 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.252141e-01 | 0.280 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.883540e-01 | 0.725 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.232226e-01 | 0.490 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.150063e-01 | 0.502 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.000477e-01 | 0.699 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.494587e-01 | 0.603 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.799893e-01 | 0.553 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 4.218886e-01 | 0.375 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.795344e-01 | 0.421 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.488539e-01 | 0.348 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.585619e-01 | 0.587 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.306293e-01 | 0.275 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.494993e-01 | 0.260 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.616125e-01 | 0.442 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.551601e-01 | 0.593 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.296716e-01 | 0.482 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.494587e-01 | 0.603 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 4.727285e-01 | 0.325 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.664699e-01 | 0.436 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.087018e-01 | 0.510 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.507157e-01 | 0.259 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.503548e-01 | 0.346 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.829348e-01 | 0.316 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.421659e-01 | 0.466 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.421659e-01 | 0.466 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.448785e-01 | 0.462 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.954600e-01 | 0.305 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.087018e-01 | 0.510 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.045174e-01 | 0.689 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.660396e-01 | 0.436 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.660396e-01 | 0.436 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.493355e-01 | 0.347 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.676886e-01 | 0.330 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.829348e-01 | 0.316 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.548416e-01 | 0.342 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.165001e-01 | 0.665 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.049999e-01 | 0.688 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.788871e-01 | 0.555 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.916060e-01 | 0.308 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.238500e-01 | 0.281 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.252141e-01 | 0.280 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.408477e-01 | 0.618 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.302717e-01 | 0.366 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.302717e-01 | 0.366 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.507157e-01 | 0.259 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.916060e-01 | 0.308 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.788871e-01 | 0.555 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.965115e-01 | 0.402 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.510464e-01 | 0.346 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.257549e-01 | 0.487 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.224555e-01 | 0.653 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.508800e-01 | 0.259 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.518497e-01 | 0.258 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.666879e-01 | 0.247 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.666883e-01 | 0.247 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.679142e-01 | 0.246 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.679142e-01 | 0.246 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.679142e-01 | 0.246 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.693266e-01 | 0.245 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.720001e-01 | 0.243 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.720001e-01 | 0.243 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.720001e-01 | 0.243 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.720001e-01 | 0.243 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.720001e-01 | 0.243 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.729591e-01 | 0.242 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.794288e-01 | 0.237 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.799361e-01 | 0.237 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.805225e-01 | 0.236 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.805225e-01 | 0.236 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.805225e-01 | 0.236 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.809937e-01 | 0.236 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.809937e-01 | 0.236 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.852738e-01 | 0.233 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.852738e-01 | 0.233 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 5.852738e-01 | 0.233 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.852738e-01 | 0.233 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.852738e-01 | 0.233 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.852738e-01 | 0.233 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.852738e-01 | 0.233 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.914462e-01 | 0.228 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.923441e-01 | 0.227 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.923441e-01 | 0.227 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.941035e-01 | 0.226 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.941035e-01 | 0.226 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.941035e-01 | 0.226 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.941035e-01 | 0.226 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.941035e-01 | 0.226 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.941035e-01 | 0.226 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.941035e-01 | 0.226 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.969192e-01 | 0.224 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.973539e-01 | 0.224 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.973539e-01 | 0.224 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.009925e-01 | 0.221 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.027956e-01 | 0.220 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.033175e-01 | 0.219 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.035266e-01 | 0.219 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.045720e-01 | 0.219 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.045720e-01 | 0.219 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.100102e-01 | 0.215 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.121902e-01 | 0.213 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.153409e-01 | 0.211 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.153409e-01 | 0.211 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.153409e-01 | 0.211 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.153409e-01 | 0.211 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.153409e-01 | 0.211 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.153409e-01 | 0.211 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.165972e-01 | 0.210 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.171756e-01 | 0.210 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.171756e-01 | 0.210 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.171756e-01 | 0.210 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.171756e-01 | 0.210 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.171756e-01 | 0.210 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.171756e-01 | 0.210 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.171756e-01 | 0.210 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.171756e-01 | 0.210 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.171756e-01 | 0.210 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.171756e-01 | 0.210 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.171756e-01 | 0.210 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.184464e-01 | 0.209 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.202832e-01 | 0.207 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.266834e-01 | 0.203 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.327869e-01 | 0.199 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.357148e-01 | 0.197 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.358232e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.365729e-01 | 0.196 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.367476e-01 | 0.196 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.367476e-01 | 0.196 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.408267e-01 | 0.193 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.459361e-01 | 0.190 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.466253e-01 | 0.189 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.466253e-01 | 0.189 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.466253e-01 | 0.189 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.466253e-01 | 0.189 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.466253e-01 | 0.189 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.466253e-01 | 0.189 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.513998e-01 | 0.186 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.527061e-01 | 0.185 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.527061e-01 | 0.185 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.546144e-01 | 0.184 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.552322e-01 | 0.184 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.552322e-01 | 0.184 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.552322e-01 | 0.184 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.552322e-01 | 0.184 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.552322e-01 | 0.184 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.552322e-01 | 0.184 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.558246e-01 | 0.183 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.569438e-01 | 0.182 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.625604e-01 | 0.179 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.640278e-01 | 0.178 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.646944e-01 | 0.177 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.651680e-01 | 0.177 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.680424e-01 | 0.175 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.681560e-01 | 0.175 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.681560e-01 | 0.175 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.720085e-01 | 0.173 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.734946e-01 | 0.172 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.738110e-01 | 0.171 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 6.738110e-01 | 0.171 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 6.738110e-01 | 0.171 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.738110e-01 | 0.171 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.738110e-01 | 0.171 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.738110e-01 | 0.171 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.738110e-01 | 0.171 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.739043e-01 | 0.171 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.739043e-01 | 0.171 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.739043e-01 | 0.171 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.739043e-01 | 0.171 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.739043e-01 | 0.171 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.782645e-01 | 0.169 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.814050e-01 | 0.167 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.830971e-01 | 0.166 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.830971e-01 | 0.166 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.830971e-01 | 0.166 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.841992e-01 | 0.165 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.841992e-01 | 0.165 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.843660e-01 | 0.165 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.862787e-01 | 0.163 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.908924e-01 | 0.161 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.917458e-01 | 0.160 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.917458e-01 | 0.160 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.933922e-01 | 0.159 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.933922e-01 | 0.159 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.938084e-01 | 0.159 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.946721e-01 | 0.158 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.969016e-01 | 0.157 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.975307e-01 | 0.156 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.981588e-01 | 0.156 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.989068e-01 | 0.156 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 6.989068e-01 | 0.156 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 6.989068e-01 | 0.156 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.989068e-01 | 0.156 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.028163e-01 | 0.153 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.087737e-01 | 0.149 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.087737e-01 | 0.149 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.087737e-01 | 0.149 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.087737e-01 | 0.149 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.087737e-01 | 0.149 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.111814e-01 | 0.148 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.134978e-01 | 0.147 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.154186e-01 | 0.145 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.181145e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.220733e-01 | 0.141 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.220733e-01 | 0.141 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.220733e-01 | 0.141 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.220733e-01 | 0.141 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.220733e-01 | 0.141 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.220733e-01 | 0.141 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.220733e-01 | 0.141 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.220733e-01 | 0.141 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.220733e-01 | 0.141 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.220733e-01 | 0.141 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.220733e-01 | 0.141 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.220733e-01 | 0.141 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.248893e-01 | 0.140 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.248893e-01 | 0.140 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.248893e-01 | 0.140 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.248893e-01 | 0.140 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.248893e-01 | 0.140 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.250077e-01 | 0.140 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.250077e-01 | 0.140 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.250077e-01 | 0.140 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.250077e-01 | 0.140 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.250077e-01 | 0.140 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.250077e-01 | 0.140 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.250077e-01 | 0.140 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.274499e-01 | 0.138 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.378247e-01 | 0.132 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.378247e-01 | 0.132 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.404692e-01 | 0.130 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.404692e-01 | 0.130 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.404692e-01 | 0.130 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.404692e-01 | 0.130 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.409666e-01 | 0.130 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.411227e-01 | 0.130 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.434585e-01 | 0.129 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 7.434585e-01 | 0.129 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.434585e-01 | 0.129 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.434585e-01 | 0.129 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.434585e-01 | 0.129 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.434585e-01 | 0.129 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.434740e-01 | 0.129 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.463116e-01 | 0.127 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.463116e-01 | 0.127 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.502733e-01 | 0.125 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.502733e-01 | 0.125 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.506862e-01 | 0.125 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.518531e-01 | 0.124 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.551807e-01 | 0.122 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.551807e-01 | 0.122 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.560396e-01 | 0.121 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.560396e-01 | 0.121 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.603222e-01 | 0.119 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.623843e-01 | 0.118 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.631994e-01 | 0.117 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.631994e-01 | 0.117 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.631994e-01 | 0.117 | 1 | 1 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.631994e-01 | 0.117 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.631994e-01 | 0.117 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.631994e-01 | 0.117 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.631994e-01 | 0.117 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.631994e-01 | 0.117 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.653952e-01 | 0.116 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.672713e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.672713e-01 | 0.115 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.672713e-01 | 0.115 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.691663e-01 | 0.114 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.727495e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.737430e-01 | 0.111 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.746515e-01 | 0.111 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.773593e-01 | 0.109 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.783397e-01 | 0.109 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.814224e-01 | 0.107 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.814224e-01 | 0.107 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.814224e-01 | 0.107 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.814224e-01 | 0.107 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.814224e-01 | 0.107 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.814224e-01 | 0.107 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.823983e-01 | 0.107 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.823983e-01 | 0.107 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.824504e-01 | 0.107 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.835404e-01 | 0.106 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.847828e-01 | 0.105 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.847828e-01 | 0.105 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.862879e-01 | 0.104 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.877974e-01 | 0.104 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.918911e-01 | 0.101 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.950582e-01 | 0.100 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.950582e-01 | 0.100 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.950582e-01 | 0.100 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.950582e-01 | 0.100 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.953730e-01 | 0.099 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.953730e-01 | 0.099 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.980777e-01 | 0.098 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.982440e-01 | 0.098 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.982440e-01 | 0.098 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.982440e-01 | 0.098 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.982440e-01 | 0.098 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.982440e-01 | 0.098 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.982440e-01 | 0.098 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.982440e-01 | 0.098 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.005002e-01 | 0.097 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.010488e-01 | 0.096 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.015462e-01 | 0.096 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.055242e-01 | 0.094 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.055242e-01 | 0.094 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.098773e-01 | 0.092 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.098773e-01 | 0.092 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.102173e-01 | 0.091 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 8.137719e-01 | 0.089 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.137719e-01 | 0.089 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.137719e-01 | 0.089 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.137719e-01 | 0.089 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.137719e-01 | 0.089 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.142115e-01 | 0.089 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.183464e-01 | 0.087 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.183464e-01 | 0.087 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.183833e-01 | 0.087 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.237185e-01 | 0.084 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.237185e-01 | 0.084 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.245560e-01 | 0.084 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.265735e-01 | 0.083 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.281057e-01 | 0.082 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.281057e-01 | 0.082 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.281057e-01 | 0.082 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.281057e-01 | 0.082 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.281057e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.281057e-01 | 0.082 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.290777e-01 | 0.081 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.312550e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.312550e-01 | 0.080 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.329634e-01 | 0.079 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.329634e-01 | 0.079 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.334600e-01 | 0.079 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.334600e-01 | 0.079 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.334600e-01 | 0.079 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.334600e-01 | 0.079 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.359691e-01 | 0.078 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.383101e-01 | 0.077 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.392342e-01 | 0.076 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.392342e-01 | 0.076 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.392342e-01 | 0.076 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.392342e-01 | 0.076 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.392342e-01 | 0.076 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.392342e-01 | 0.076 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.413369e-01 | 0.075 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.413369e-01 | 0.075 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.413369e-01 | 0.075 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.413369e-01 | 0.075 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.413369e-01 | 0.075 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.413369e-01 | 0.075 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.413369e-01 | 0.075 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.413369e-01 | 0.075 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.419724e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.419724e-01 | 0.075 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.434117e-01 | 0.074 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.434117e-01 | 0.074 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.434117e-01 | 0.074 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.443859e-01 | 0.073 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.460719e-01 | 0.073 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.477157e-01 | 0.072 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.487698e-01 | 0.071 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.488407e-01 | 0.071 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.488407e-01 | 0.071 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.488407e-01 | 0.071 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.492172e-01 | 0.071 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.493208e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.498603e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.498603e-01 | 0.071 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.501053e-01 | 0.071 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.535504e-01 | 0.069 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.535504e-01 | 0.069 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.535504e-01 | 0.069 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.535504e-01 | 0.069 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.563203e-01 | 0.067 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.578711e-01 | 0.067 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.579217e-01 | 0.067 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.579217e-01 | 0.067 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.579217e-01 | 0.067 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.579217e-01 | 0.067 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.579217e-01 | 0.067 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.579217e-01 | 0.067 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.611602e-01 | 0.065 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.613893e-01 | 0.065 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.641438e-01 | 0.063 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.641438e-01 | 0.063 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.648245e-01 | 0.063 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.648245e-01 | 0.063 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.648245e-01 | 0.063 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.648245e-01 | 0.063 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.648245e-01 | 0.063 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.648245e-01 | 0.063 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.648245e-01 | 0.063 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.652822e-01 | 0.063 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.665012e-01 | 0.062 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.670474e-01 | 0.062 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.707225e-01 | 0.060 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.714576e-01 | 0.060 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.746025e-01 | 0.058 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.746025e-01 | 0.058 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.750569e-01 | 0.058 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.752312e-01 | 0.058 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.752312e-01 | 0.058 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.752312e-01 | 0.058 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.752312e-01 | 0.058 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.752312e-01 | 0.058 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.802944e-01 | 0.055 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.811623e-01 | 0.055 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.822484e-01 | 0.054 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.822484e-01 | 0.054 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.848374e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.848374e-01 | 0.053 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.848374e-01 | 0.053 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.848374e-01 | 0.053 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.848374e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.855092e-01 | 0.053 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.879312e-01 | 0.052 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.880333e-01 | 0.052 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.894609e-01 | 0.051 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.894609e-01 | 0.051 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.894609e-01 | 0.051 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.906928e-01 | 0.050 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.914682e-01 | 0.050 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.916233e-01 | 0.050 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.937045e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.937045e-01 | 0.049 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.937045e-01 | 0.049 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.937045e-01 | 0.049 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.937045e-01 | 0.049 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.937045e-01 | 0.049 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.939797e-01 | 0.049 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.939797e-01 | 0.049 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.962615e-01 | 0.048 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.962615e-01 | 0.048 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.962615e-01 | 0.048 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.962615e-01 | 0.048 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.965059e-01 | 0.047 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.966648e-01 | 0.047 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.974429e-01 | 0.047 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.979481e-01 | 0.047 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.018893e-01 | 0.045 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.018893e-01 | 0.045 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.018893e-01 | 0.045 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.022404e-01 | 0.045 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.026708e-01 | 0.044 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.026708e-01 | 0.044 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.026708e-01 | 0.044 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.042070e-01 | 0.044 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.052145e-01 | 0.043 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.080822e-01 | 0.042 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.087086e-01 | 0.042 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.092937e-01 | 0.041 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.094444e-01 | 0.041 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.094444e-01 | 0.041 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.094444e-01 | 0.041 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.094444e-01 | 0.041 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.094444e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.094444e-01 | 0.041 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.097853e-01 | 0.041 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.117102e-01 | 0.040 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.132498e-01 | 0.039 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.160676e-01 | 0.038 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.164181e-01 | 0.038 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.164181e-01 | 0.038 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.164181e-01 | 0.038 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.164181e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.164181e-01 | 0.038 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.164181e-01 | 0.038 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.164181e-01 | 0.038 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.197461e-01 | 0.036 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.197461e-01 | 0.036 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.197461e-01 | 0.036 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.197461e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.197461e-01 | 0.036 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.207922e-01 | 0.036 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.216887e-01 | 0.035 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.225214e-01 | 0.035 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.227137e-01 | 0.035 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.228551e-01 | 0.035 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.239632e-01 | 0.034 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.239632e-01 | 0.034 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.244748e-01 | 0.034 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.247818e-01 | 0.034 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.247818e-01 | 0.034 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.247818e-01 | 0.034 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.247818e-01 | 0.034 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.247818e-01 | 0.034 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.247818e-01 | 0.034 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.247818e-01 | 0.034 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.247818e-01 | 0.034 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.287967e-01 | 0.032 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.287967e-01 | 0.032 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.287967e-01 | 0.032 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.287967e-01 | 0.032 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.287967e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.287967e-01 | 0.032 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.295184e-01 | 0.032 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.305001e-01 | 0.031 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.305001e-01 | 0.031 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.339719e-01 | 0.030 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.339719e-01 | 0.030 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.342811e-01 | 0.030 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.342811e-01 | 0.030 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.342811e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.342811e-01 | 0.030 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.342811e-01 | 0.030 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.342811e-01 | 0.030 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.342811e-01 | 0.030 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.353876e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.353876e-01 | 0.029 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.381579e-01 | 0.028 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.383971e-01 | 0.028 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.393433e-01 | 0.027 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.393433e-01 | 0.027 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.393433e-01 | 0.027 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.393433e-01 | 0.027 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.393433e-01 | 0.027 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.393433e-01 | 0.027 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.413975e-01 | 0.026 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.440159e-01 | 0.025 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.457857e-01 | 0.024 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.482675e-01 | 0.023 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.483287e-01 | 0.023 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.483287e-01 | 0.023 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.483287e-01 | 0.023 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.492550e-01 | 0.023 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.502293e-01 | 0.022 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.506394e-01 | 0.022 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.512161e-01 | 0.022 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.523096e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.525118e-01 | 0.021 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.525118e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.525118e-01 | 0.021 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.525118e-01 | 0.021 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.556824e-01 | 0.020 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.556824e-01 | 0.020 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.559840e-01 | 0.020 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.559840e-01 | 0.020 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.559840e-01 | 0.020 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.593755e-01 | 0.018 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.593755e-01 | 0.018 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.593755e-01 | 0.018 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.625059e-01 | 0.017 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.625059e-01 | 0.017 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.625059e-01 | 0.017 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.625059e-01 | 0.017 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.625059e-01 | 0.017 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.625059e-01 | 0.017 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.625059e-01 | 0.017 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.625059e-01 | 0.017 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.626624e-01 | 0.017 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.636480e-01 | 0.016 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.653952e-01 | 0.015 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.653952e-01 | 0.015 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.653952e-01 | 0.015 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.653952e-01 | 0.015 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.653952e-01 | 0.015 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.662814e-01 | 0.015 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.663023e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.671657e-01 | 0.014 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.671657e-01 | 0.014 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.671657e-01 | 0.014 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.680620e-01 | 0.014 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.680620e-01 | 0.014 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.680620e-01 | 0.014 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.686523e-01 | 0.014 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.696641e-01 | 0.013 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.702765e-01 | 0.013 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.703055e-01 | 0.013 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.705235e-01 | 0.013 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.705235e-01 | 0.013 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.705235e-01 | 0.013 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.705235e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.705235e-01 | 0.013 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.714543e-01 | 0.013 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.715152e-01 | 0.013 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.722510e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.722510e-01 | 0.012 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.725148e-01 | 0.012 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.726194e-01 | 0.012 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.727954e-01 | 0.012 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.727954e-01 | 0.012 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.731955e-01 | 0.012 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.740170e-01 | 0.011 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.740732e-01 | 0.011 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.740732e-01 | 0.011 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.744797e-01 | 0.011 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.748923e-01 | 0.011 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.748923e-01 | 0.011 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.748923e-01 | 0.011 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.748923e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.757794e-01 | 0.011 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.757794e-01 | 0.011 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.762781e-01 | 0.010 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.768277e-01 | 0.010 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.768277e-01 | 0.010 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.768277e-01 | 0.010 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.774526e-01 | 0.010 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.786140e-01 | 0.009 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.786140e-01 | 0.009 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.786140e-01 | 0.009 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.788720e-01 | 0.009 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.790124e-01 | 0.009 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.802627e-01 | 0.009 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.802627e-01 | 0.009 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.802627e-01 | 0.009 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.802773e-01 | 0.009 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.814610e-01 | 0.008 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.817844e-01 | 0.008 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.817844e-01 | 0.008 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.817844e-01 | 0.008 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.817844e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.817844e-01 | 0.008 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.818477e-01 | 0.008 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.822760e-01 | 0.008 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.822760e-01 | 0.008 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.831889e-01 | 0.007 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.831889e-01 | 0.007 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.831889e-01 | 0.007 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.836376e-01 | 0.007 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.839505e-01 | 0.007 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.839505e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.844851e-01 | 0.007 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.844851e-01 | 0.007 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.855512e-01 | 0.006 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.855762e-01 | 0.006 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.855877e-01 | 0.006 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.856815e-01 | 0.006 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.856815e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.860231e-01 | 0.006 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.864013e-01 | 0.006 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.867857e-01 | 0.006 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.867857e-01 | 0.006 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.867857e-01 | 0.006 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.867956e-01 | 0.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.872567e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.880351e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.886519e-01 | 0.005 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.887453e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.887678e-01 | 0.005 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.890868e-01 | 0.005 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.890868e-01 | 0.005 | 1 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.892391e-01 | 0.005 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.894571e-01 | 0.005 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.896134e-01 | 0.005 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.901056e-01 | 0.004 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.901295e-01 | 0.004 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.901888e-01 | 0.004 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.904146e-01 | 0.004 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.907156e-01 | 0.004 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.911540e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.911540e-01 | 0.004 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.911540e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.911540e-01 | 0.004 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.912892e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.914186e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.919970e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.920000e-01 | 0.003 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.924662e-01 | 0.003 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.924662e-01 | 0.003 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.927533e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.930475e-01 | 0.003 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.930475e-01 | 0.003 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.931280e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.933422e-01 | 0.003 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.935839e-01 | 0.003 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.936805e-01 | 0.003 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.944159e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.944356e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.945359e-01 | 0.002 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.947956e-01 | 0.002 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.950544e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.951488e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.953467e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.953467e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.957059e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.957059e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.957187e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.960373e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.963266e-01 | 0.002 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.963432e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.965955e-01 | 0.001 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.965992e-01 | 0.001 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.966255e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.966255e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.968889e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.970349e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.973224e-01 | 0.001 | 1 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.973483e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.974306e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.974306e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.975530e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.976660e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.977478e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.977478e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.977742e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.980725e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.980725e-01 | 0.001 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.980772e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.982065e-01 | 0.001 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.982065e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.982257e-01 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.983751e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.986059e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.986566e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.987136e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.987136e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.987504e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.987673e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.988339e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.989191e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.989893e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.989893e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.989893e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.992981e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.993467e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.994235e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.994922e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.995479e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.995756e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.995828e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.996387e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.996585e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.996882e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.997702e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998135e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998432e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998510e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999054e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999268e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999456e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999486e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999662e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999852e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999920e-01 | 0.000 | 1 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999923e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999968e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999968e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999978e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999978e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999981e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999982e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999986e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999988e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999992e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999993e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999994e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |